<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Infect Microbiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Infect Microbiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
</journal-title-group>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29616193</article-id>
<article-id pub-id-type="pmc">5869923</article-id>
<article-id pub-id-type="doi">10.3389/fcimb.2018.00065</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A Comprehensive <italic>in Silico</italic> Analysis of Regulatory SNPs of Human CLEC7A Gene and Its Validation as Genotypic and Phenotypic Disease Marker in Recurrent Vulvovaginal Infections</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kalia</surname>
<given-names>Namarta</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/384778/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaur</surname>
<given-names>Manpreet</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/407131/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Sujata</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Jatinder</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/407128/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Molecular Biology &amp; Biochemistry, Guru Nanak Dev University</institution>, <addr-line>Amritsar</addr-line>, <country>India</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Human Genetics, Guru Nanak Dev University</institution>, <addr-line>Amritsar</addr-line>, <country>India</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Gynaecology &amp; Obstetrics, Bebe Nanki Mother and Child Care Centre, Government Medical College</institution>, <addr-line>Amritsar</addr-line>, <country>India</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: D. Scott Merrell, Uniformed Services University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Hellen Thais Fuzii, Universidade Federal do Pará, Brazil; Igor Brasil-Costa, Instituto Evandro Chagas, Brazil</p>
</fn>
<corresp id="fn001">*Correspondence: Manpreet Kaur <email xlink:type="simple">dr.manpreetdhuna@gmail.com</email></corresp>
<corresp id="fn002">Jatinder Singh <email xlink:type="simple">jatinderarora2009@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>8</volume>
<elocation-id>65</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>2</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Kalia, Kaur, Sharma and Singh.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Kalia, Kaur, Sharma and Singh</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Recurrent Vulvovaginal infections (RVVI) are the commonly reported microbiological syndrome affecting millions of women globally. Various molecules of innate immune system are instrumental in clearance of these microbial pathogens, thus suggested as one of the most important contributing factor in determining the disease outcome. Dendritic cell-associated C-type lectin-1 (Dectin-1) is an important molecule of innate immunity that is primarily known for its role in antifungal defenses. However, role of dectin-1 in recognition of other pathogens is also documented. The intracellular expression of dectin-1 was shown to be up-regulated by Mannose Binding Lectin (MBL)-mediated opsonophagocytosis of pathogens. Dectin-1 is encoded by <italic>CLEC7A</italic>, postulated to be a candidate gene in modulating risk of developing RVVI. In this study, we identified <italic>CLEC7A</italic> causal variants using <italic>in silico</italic> analysis. To assess their impact on susceptibility to RVVI, these causal variants along with serum dectin-1 levels (sDectin-1) were investigated using polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP) and Enzyme Linked Immnosorbent Assay (ELISA) respectively, under a case-control design. Furthermore, effect of these polymorphisms was also assessed on sMBL levels. <italic>In silico</italic> analysis revealed 9 putative functional conserved SNPs of <italic>CLEC7A</italic>. Association analysis revealed a significantly lower risk of developing RVVI and its types in carriers of <italic>CLEC7A</italic> rs3901533 G allele and its homozygous genotypes (<italic>p</italic> &lt; 0.05). The heterozygous genotype was associated with significant protection against RVVI (<italic>p</italic> = 0.004). Haplotypes GGG and GTA showed significant protection against RVVI (<italic>p</italic> &lt; 0.0001; <italic>p</italic> = 0.0003), Bacterial Vaginosis (<italic>p</italic> = 0.03; <italic>p</italic> = 0.002), Vulvovaginal Candidiasis (<italic>p</italic> = 0.03; <italic>p</italic> = 0.01) and Mixed Infections (<italic>p</italic> = 0.007; <italic>p</italic> = 0.04). Mean sDectin-1 levels were significantly high in RVVI and its types compared to controls (<italic>p</italic> &lt; 0.05). Further, genotype-phenotype stratification showed significant differences within/between cases groups and controls. The <italic>CLEC7A</italic> rs3901533 polymorphism was also found to be associated with sMBL levels. The present study contributed novel insights into the role of dectin-1 in RVVI. <italic>CLEC7A</italic> rs3901533 polymorphism and high sDectin-1 levels along with low sMBL levels were found to be associated with RVVI susceptibility. Thus, screening of women with RVVI for these novel associations may lead to better diagnosis and treatment. Also genotyping method used in this study constitutes a simple and reliable assay, which can be confidently, used as a cheaper alternative for genotyping these variants in clinical settings. Finally, new restorative markers for other infectious diseases might be found by exploring nine functionally identified <italic>CLEC7A</italic> SNPs.</p>
</abstract>
<kwd-group>
<kwd>bacterial vaginosis</kwd>
<kwd>serum Dectin-1(sDectin-1)</kwd>
<kwd>mannose binding Lectin</kwd>
<kwd>mixed infections</kwd>
<kwd>PCR-RFLP</kwd>
<kwd>vulvovaginal candidiasis</kwd>
</kwd-group>
<counts>
<fig-count count="11"></fig-count>
<table-count count="6"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="81"></ref-count>
<page-count count="20"></page-count>
<word-count count="12048"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Vulvovaginal infections (VVI) are the commonly reported microbiological syndrome affecting millions of women globally in all strata of society. An abnormal vaginal discharge is a key trait of VVI and its estimated prevalence in India is 30% (Thulkar et al., <xref ref-type="bibr" rid="B69">2010</xref>). Bacterial Vaginosis (BV), Vulvovaginal Candidiasis (VVC), and Trichomoniasis (TV) are the three main causes of VVI (Mulu et al., <xref ref-type="bibr" rid="B51">2015</xref>). Mutual existence of these causes is termed as Mixed Infections (MI) that contribute &gt;20% of women with VVI (French et al., <xref ref-type="bibr" rid="B22">2004</xref>; Kalia et al., <xref ref-type="bibr" rid="B38">2015</xref>). Besides this, cases of recurrent VVI (RVVI) have also emerged that is commonly stated as repeated experiences of vaginal infections in a definite period, this includes recurrent VVC (RVVC) and recurrent BV (RBV). RVVC refers to ≥4 repeated episodes of VVC in 12-months while RBV refers to the repeated episodes of BV within 3 months with recurrence rates as high as 30–50% (Powell and Nyirjesy, <xref ref-type="bibr" rid="B58">2014</xref>).</p>
<p>Literature regarding RVVI pathogenesis suggests that it is caused by a fall in hydrogen peroxide producing lactobacilli and overgrowth of microbes that are either normally present in human vaginal microbiome in lower quantity or sexually transmitted. Pictorial representation of various pathophysiological variations in vaginal flora during RVVI is depicted in Figure <xref ref-type="fig" rid="F1">1</xref> (Sobel, <xref ref-type="bibr" rid="B65">1988</xref>; Forsum et al., <xref ref-type="bibr" rid="B20">2005</xref>; Hickey et al., <xref ref-type="bibr" rid="B32">2012</xref>; Li J. et al., <xref ref-type="bibr" rid="B45">2012</xref>). In addition, use of contraceptives, excessive antibiotics, smoking, sexual activity, immunosuppression, and black race are the other known predisposing factors that leads to RVVI (Bleicher and Stockdale, <xref ref-type="bibr" rid="B9">2015</xref>; Sobel, <xref ref-type="bibr" rid="B66">2016</xref>). Untreated RVVI can lead to complications like infertility, pre-term birth, miscarriage, vulvovaginal inflammation, and other infectious diseases (Hay et al., <xref ref-type="bibr" rid="B28">1994</xref>; McClelland et al., <xref ref-type="bibr" rid="B47">2007</xref>; Atashili et al., <xref ref-type="bibr" rid="B2">2008</xref>; Toth et al., <xref ref-type="bibr" rid="B71">2015</xref>). Though diverse microbial strains have been defined in literature as a causative agent for RVVI, till date no major determinants have been recognized that could explain susceptibility to this disease condition (van de Wijgert et al., <xref ref-type="bibr" rid="B73">2014</xref>). So, it was hypothesized that RVVI susceptibility may be determined by individual's own genetic factors.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Model of vaginal microbiome disruption and induced conditions during RVVI <bold>(A)</bold>. Healthy vaginal microbiome: abundance of <italic>Lactobacillus</italic>- the Gram-positive rods, a low pH (3.5–4.5), small numbers of <italic>Candida</italic> species- a dimorphic yeast, small volume of white clear flocculent fluid and the absence of both facultative and obligatory anaerobic Gram-negative rods. Microbiome during RVVI <bold>(B)</bold> BV: is typified by decrease in hydrogen peroxide producing <italic>Lactobacilli</italic>, overgrowth of predominantly anaerobic organisms of the genera <italic>Atopobium, Prevotella, Mobiluncus</italic>, and <italic>Sneathia</italic> in the vagina, increase vaginal discharge with fishy odor and rise in pH. <bold>(C)</bold> VVC: decrease in hydrogen peroxide producing <italic>Lactobacilli</italic> and overgrowth of <italic>C. albicans</italic> that undergo morphogenetic change from yeast cell to a hyphal mycelial growing organism (dimorphic transition). These hyphae strongly adhere to, and then invade, the outermost layer of the vaginal epithelium. Detachment of the Hyphae from the epithelium, together with recruited inflammatory cells, debris from lysed cells and vaginal fluid make up the curd white vaginal discharge <bold>(D)</bold> TV: adhesion of trichomonads to the epithelial cells in the vaginal environment is a critical step in the pathogenesis of this parasite. Also increase vaginal discharge with fishy odor and rise in pH.</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0001"></graphic>
</fig>
<p>These genetic factors include pattern recognition receptors (PRRs) that identify preserved biomolecular structures on surface of pathogens also known as pathogen associated molecular patterns (PAMPs). This interaction further leads to the generation of specific immune responses against pathogens (Kumar et al., <xref ref-type="bibr" rid="B41">2011</xref>; Santoni et al., <xref ref-type="bibr" rid="B62">2015</xref>). The toll-like receptor (TLR) family of PRRs contributes crucially in pathogen recognition and immune responses generation. However, the attention has now been restored to non-TLR PRRs, particularly C-type lectin receptors (CLRs) which are Ca<sup>2+</sup>-dependent carbohydrate binding proteins. Of these, the one typical member is Dendritic cell-associated C-type lectin-1 (Dectin-1) (Brown, <xref ref-type="bibr" rid="B12">2006</xref>).</p>
<p>Human dectin-1 is expressed as a monomer both on surface as well as in cytoplasm of myeloid cells and lymphocytes (Brown, <xref ref-type="bibr" rid="B12">2006</xref>). It is a 28 kDa glycosylated type II transmembrane receptor encoded by <italic>CLEC7A</italic> mapped to 12p13.2 (Ariizumi et al., <xref ref-type="bibr" rid="B1">2000</xref>). Differential splicing of precursor mRNA of dectin-1 leads to the formation of two chief isoforms A and B, both having surface expression but different functionalities (Willment et al., <xref ref-type="bibr" rid="B75">2001</xref>, <xref ref-type="bibr" rid="B76">2005</xref>; Heinsbroek et al., <xref ref-type="bibr" rid="B30">2006</xref>; Del Pilar Jimenez et al., <xref ref-type="bibr" rid="B15">2008</xref>). Isoform A has a surface C-type lectin-like domain (CTLD) that is attached to an intracellular immune receptor tyrosine-based activation motif (ITAM) via stalk and region across the membrane. However, isoform B is characterized by absence of stalk. Alternative splicing also generates six minor isoforms of dectin-1, one of which is isoform E. This isoform do not have stalk and transmembrane region, thus have cytoplasmic expression and interaction with other cytosolic proteins (Xie et al., <xref ref-type="bibr" rid="B78">2006</xref>). However, the function of other minor isoforms remains poorly stated.</p>
<p>Dectin-1 recognize 1,3-β-glucans on the surface of pathogens including fungi and some bacteria. This receptor ligand interaction leads to intracellular signaling through Raf-1 and Syk-CARD9 pathway, that further causes pro-inflammatory signaling proteins expression and cytotoxic T-cell responses (LeibundGut-Landmann et al., <xref ref-type="bibr" rid="B43">2007</xref>; Gerosa et al., <xref ref-type="bibr" rid="B24">2008</xref>; Heinsbroek et al., <xref ref-type="bibr" rid="B29">2008</xref>; Gringhuis et al., <xref ref-type="bibr" rid="B26">2009</xref>). Dectin-1 is primarily known for its role in antifungal defenses. However, role of dectin-1 in recognition of other pathogens including <italic>Mycobacterium tuberculosis, Salmonella typhimurium, Leishmania infantum, and Haemophilus influenzae</italic> is also documented (Drummond and Brown, <xref ref-type="bibr" rid="B16">2013</xref>; Lefèvre et al., <xref ref-type="bibr" rid="B42">2013</xref>; Heyl et al., <xref ref-type="bibr" rid="B31">2014</xref>). However, these pathogens do not possess β-glucans, suggesting the possibility of other ligands of Dectin-1 that are still not revealed.</p>
<p>Interestingly, a study has highlighted the specific role of <italic>CLEC7A</italic> rs16910526 (Y238X) polymorphism in antifungal defenses in four women from Netherlands, affected either by onychomycosis or RVVC (Ferwerda et al., <xref ref-type="bibr" rid="B18">2009</xref>). However, no correlation of this polymorphism was found in susceptibility to RVVC in three different populations i.e., Turkish, western-european, and Iranian (Rosentul et al., <xref ref-type="bibr" rid="B60">2014</xref>; Usluogullari et al., <xref ref-type="bibr" rid="B72">2014</xref>; Zahedi et al., <xref ref-type="bibr" rid="B81">2016</xref>). Irrespective of the prime role of dectin-1 in antifungal activity, its aforesaid role in recognition and generation of immune responses against bacterial and other pathogens cannot be ignored. This led us to evaluate the role of <italic>CLEC7A</italic> polymorphisms in RVVI and its types that has not been investigated earlier. Also, functional implications of only few SNPs of <italic>CLEC7A</italic> are known out of 1179 SNPs in dbSNP, as of October, 2016 while majority of SNPs are still not established (Sherry et al., <xref ref-type="bibr" rid="B64">2001</xref>; Bhagwat, <xref ref-type="bibr" rid="B6">2010</xref>). Therefore, to predict the putative functional consequences, all the SNPs of <italic>CLEC7A</italic> were analyzed using different bioinformatic tools (Bhatti et al., <xref ref-type="bibr" rid="B8">2006</xref>; Johnson, <xref ref-type="bibr" rid="B35">2009</xref>; Li and Wei, <xref ref-type="bibr" rid="B46">2015</xref>). Also, studies have suggested the release of cytosolic proteins from the cells by non-classical secretary pathways (Cooper and Barondes, <xref ref-type="bibr" rid="B14">1990</xref>; Kuchler and Thorner, <xref ref-type="bibr" rid="B40">1990</xref>; Muesch et al., <xref ref-type="bibr" rid="B50">1990</xref>; Muthukrishnan et al., <xref ref-type="bibr" rid="B53">1991</xref>). Furthermore, it was proposed that Dectin-1/Syk signaling pathway leads to protein secretion by non-classical secretary means in human macrophages (Öhman et al., <xref ref-type="bibr" rid="B54">2014</xref>). This directed us to determine the unconventional release of cytoplasmic form of dectin-1 in serum (sDectin-1) of RVVI cases and controls.</p>
<p>Moreover, Dectin-1 has been shown to collaborate with other PRRs including TLRs and CLRs through Syk pathway to induce optimal immune responses (Brown, <xref ref-type="bibr" rid="B12">2006</xref>). Human Mannose-Binding Lectin (MBL) is a CLR that provides defense against a variety of pathogens (Eisen and Minchinton, <xref ref-type="bibr" rid="B17">2003</xref>; Brouwer et al., <xref ref-type="bibr" rid="B11">2008</xref>; Kasperkiewicz et al., <xref ref-type="bibr" rid="B39">2015</xref>; Kalia et al., <xref ref-type="bibr" rid="B37">2017</xref>). Our previous findings have indicated the association of low sMBL levels with susceptibility to RVVI (Kalia et al., <xref ref-type="bibr" rid="B37">2017</xref>). Both dectin-1 and MBL are the important components of innate immunity. However, how these two PRRs interact with each other, when co-activated, has not been reported till date. The only study that so far collaborate the two PRRs has shown that intracellular expression of dectin-1 increases with MBL-arbitrated opsonophagocytosis of pathogens (Li D. et al., <xref ref-type="bibr" rid="B44">2012</xref>). This may subsequently lead to increased serum concentration of dectin-1 by unconventional release of its increased intracellular protein (Öhman et al., <xref ref-type="bibr" rid="B54">2014</xref>). To find the relationship between sDectin-1 and sMBL, if any, the correlation analysis was carried out. In addition it has been reported that variations in dectin-1 gene modulates its protein expression, ligand binding ability and thus generate non optimal immune responses through defective collaborations (Ferwerda et al., <xref ref-type="bibr" rid="B18">2009</xref>). Using this rational, the association of <italic>CLEC7A</italic> polymorphisms was also explored with serum MBL (sMBL) levels.</p>
<p>Thus, the current investigation involves sorting of underlying variants from a pool of <italic>CLEC7A</italic> SNPs using <italic>in silico</italic> analysis. These functionally identified variants were further evaluated to assess their impact on susceptibility to RVVI and its types using a conventional approach. In addition, we have also investigated the serum levels of dectin-1 (sDectin-1) in cases and controls. Furthermore, sDectin-1 and sMBL levels were also correlated with <italic>CLEC7A</italic> polymorphisms. All these findings are reported for the first time in the present study.</p>
</sec>
<sec id="s2" sec-type="materials and methods">
<title>Materials and methods</title>
<sec>
<title>Ethics issues</title>
<p>The present study was commenced after getting approval from the Institutional Ethics Committee (Approval no. 06/HG dated 02/01/2015) of Guru Nanak Dev University, Amritsar (Punjab), India, in accordance with Indian Council of Medical Research guidelines (ICMR, <xref ref-type="bibr" rid="B34">2006</xref>) modified from World Medical Association (<xref ref-type="bibr" rid="B77">2004</xref>). Voluntary consent in written was attained from all the subjects. To ensure that subjects involved in the study had necessary information to make an informed choice the information provided to them include comprehensive depiction of the present study purpose, confirmation of secrecy of their provided information, vaginal, and blood samples collection procedures and possible risks and benefits of the study. The necessary information was recorded in a pre-designed Proforma. In addition, the bio-medical waste was segregated and managed on the basis of color coding as mentioned in Bio-Medical Waste (Management &amp; Handling) Rules, 1998 (amended in 2000).</p>
</sec>
<sec>
<title>Subjects and sample processing</title>
<p>The study included 258 RVVI cases (Age, mean ± S.E., 29.33 ± 0.51 years) from the Department of Gynaecology and Obstetrics, Bebe Nanki Mother and Child Care Centre, Government Medical College, Amritsar (Punjab). These recommended cases by gynecologist were clinically diagnosed with RVVI with minimum four documented recurrent experiences in a year. These cases complained of having frequent symptoms like vaginal fishy smell, burning, discharge, itching, pelvic pain, pruitis, and soreness. Participants with immunodeficiencies, using immunosuppressive medications, under chemotherapy or having HIV infections were excluded from the study. For further confirmation, 200 RVVI cases were processed on the basis of standard tests given in European (IUSTI/WHO) guidelines on vaginal discharge management (Sherrard et al., <xref ref-type="bibr" rid="B63">2011</xref>). The particulars of vaginal discharge sample collection as well as processing, diagnosis of various types of RVVI along with clinical characteristics of RVVI cases have been reported previously (Kalia et al., <xref ref-type="bibr" rid="B38">2015</xref>, <xref ref-type="bibr" rid="B37">2017</xref>). This categorized 200 RVVI cases into three classes including BV (<italic>N</italic> = 97), VVC (<italic>N</italic> = 62) and Mixed Infections (MI; N = 41). However vaginal samples from the rest of 58 cases could not be processed as some participants were reluctant to give vaginal samples and others were menstruating. Thus, these participants were not sub categorized into RVVI categories. Age matched healthy women (mean ± S.E., 29.33 ± 0.57 years, N = 203) forms the control group. These women do not have any recurrent history of vaginal infection complaints. Peripheral blood samples (5 ml) were collected from each study participant. 2.5 ml of this blood was transferred to EDTA (0.5 M) coated vial for genomic DNA isolation and the other half was transferred to plain vial without anticoagulant for serum separation. Genomic DNA isolation was performed using inorganic method by Miller et al. (<xref ref-type="bibr" rid="B49">1988</xref>) from peripheral blood mononuclear cells (PBMCs). Serum separation from blood was performed by incubating the samples for 1 h at 37°C followed by 10 min centrifugation (Spinwin, Tarson, India) at 300 × g and serum was collected as supernatant. These isolated samples both DNA and serum samples were stored at −80°C till further analysis.</p>
</sec>
<sec>
<title><italic>In silico</italic> analysis of human <italic>CLEC7A</italic> polymorphisms</title>
<p>The data mining for SNPs in Human <italic>CLEC7A</italic> was carried out using dbSNP database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/">http://www.ncbi.nlm.nih.gov/SNP/</ext-link>). These SNPs were put through different bioinformatics tools analysis. The details of computational tools used, along with scheme and criteria adopted to select the functional SNPs were reported previously (Kalia et al., <xref ref-type="bibr" rid="B36">2016</xref>). In brief, to verify the consistency of a particular SNP in dbSNP database, all the SNPs were primarily looked for validation status. Secondly, Minor Allele Frequency (MAF) was used to further prioritize the SNPs having MAF ≥ 0.10. Further, Ensembl Genome browser release 48 (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/">http://www.ensembl.org/</ext-link>) was used to recognize SNPs located in evolutionary conserved regions (cSNPs). For this, relative analysis of human <italic>CLEC7A</italic> was performed with seventeen eutherian mammals including <italic>Bos Taurus, Canis lupus familiaris, Callithrix jacchus, Chlorocebus sabaeus, Equus caballus, Felis catus, Gorilla gorilla gorilla, Macaca mulatta, Mus musculus, Ovis aries, Oryctolagus cuniculus, Pan troglodytes, Pongoabelii, Papio Anubis, Rattus norvegicus</italic>, and <italic>Sus scrofa</italic>. As, no non-synonymous SNPs (nsSNPs) of <italic>CLEC7A</italic> were found to have MAF ≥ 0.10, only tools for functional analysis of non-coding SNPs were used. These include SNPinfo (FuncPred; <ext-link ext-link-type="uri" xlink:href="https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html">https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html</ext-link>), RegulomeDB (<ext-link ext-link-type="uri" xlink:href="http://regulomedb.org/">http://regulomedb.org/</ext-link>) and PolymiRTS (v3.0) (<ext-link ext-link-type="uri" xlink:href="http://compbio.uthsc.edu/miRSNP/">http://compbio.uthsc.edu/miRSNP/</ext-link>). SNPinfo comprises of different sets of data processing elements for the selection of functional SNPs. FuncPred, the main tool of SNPinfo is composite of different singleton tools including SNP3D, rescue ESE, MATCH, miRanda, Polyphen, TRANSFAC12.1, miRBase, FAS–ESS, and ESEfinder (Xu and Taylor, <xref ref-type="bibr" rid="B79">2009</xref>). RegulomeDB divides functional SNPs into six different classes ranging from C1 to C6. Class 1 SNPs mostly include expression and binding signals, with six subclasses from 1a to 1f that further categorize SNPs by falling confidence. Class 2 SNPs are interpreted as “likely to affect binding.” The other three classes (C4–C6) correspond to weak or minimal binding evidence for the functional SNPs (Boyle et al., <xref ref-type="bibr" rid="B10">2012</xref>). PolymiRTS (v3.0) is used to recognize SNPs locating in miRNAs seed region and its complement binding sites (Bhattacharya et al., <xref ref-type="bibr" rid="B7">2014</xref>).</p>
</sec>
<sec>
<title>Polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP) for the validation of <italic>CLEC7A</italic> SNPs by genotyping</title>
<p>The present study was able to standardize PCR-RFLP, an easy low cost method, for three <italic>CLEC7A</italic> SNPs i.e., rs11053593, rs11053597, and rs3901533 to analyze their association with susceptibility to RVVI.</p>
<sec>
<title>Design of PCR primers for PCR-RFLP</title>
<p>Primers for PCR amplification of rs11053593, rs11053597, and rs3901533 SNPs were designed using the online software Primer-BLAST (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/tools/primer-blast/">https://www.ncbi.nlm.nih.gov/tools/primer-blast/</ext-link>) and Primer3 (<ext-link ext-link-type="uri" xlink:href="http://bioinfo.ut.ee/primer3-0.4.0/">http://bioinfo.ut.ee/primer3-0.4.0/</ext-link>). The flanking sequence of the given SNP, based on the size of PCR product required, was obtained from the <italic>CLEC7A</italic> gene sequence (NCBI Reference Sequence: <ext-link ext-link-type="NCBI:refseq" xlink:href="NC_000012.12">NC_000012.12</ext-link>). The best primer pair was selected based on the optimal GC content of 40–60% and the difference of GC content between forward and reverse primers &lt;10%. The oligos were custom-synthesized by Bioserve Biotechnologies (Hyderabad, India). PCR was carried out using target DNA (3 ng/ul), deoxynucleotide triphosphate (0.05 mM each), appropriate forward and reverse primers (0.15 pmol each), Taq DNA polymerase (0.3 U) and polymerase buffer with 1.5 μM MgCl<sub>2</sub> (1X) in 20 μl reaction volumes (GeNei, Bangalore). All PCRs were carried out in a thermocycler with pre-set conditions (Applied Biosystems, Life Technologies, USA). Primer sequences along with the PCR conditions used for each reaction are given in Table <xref ref-type="table" rid="T1">1A</xref>. Ethidium bromide (SRL, India) stained agarose gel (1.5% w/v; Himedia, India) was prepared and amplified products were loaded in it. These products were visualized using gel documentation system (Alpha imagner, USA) after electrophoresis at 100 V.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>PCR-RFLP protocol for the detection of <italic>CLEC7A</italic> polymorphisms.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="6" rowspan="1" valign="top"><bold>(A) PCR primers and conditions</bold>.</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>SNP</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Primers</bold>
</td>
<td align="left" colspan="2" rowspan="1" valign="top">
<bold>Sequence (5′ → 3′)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Conditions for both reactions</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>PCR product</bold>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">rs11053593<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref>,<break></break>rs11053597<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Forward</td>
<td align="left" colspan="2" rowspan="1" valign="top">ACATGGCAAAACCCAGTCTC</td>
<td align="left" colspan="1" rowspan="1" valign="top">94°C for 5 min, followed by 34 cycles (94°C for 30 s, 63°C for 30 s, and 72°C for 30 s) and a final elongation at 72°C for 5 min</td>
<td align="left" colspan="1" rowspan="1" valign="top">551 bp</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Reverse</td>
<td align="left" colspan="2" rowspan="1" valign="top">ACCCAAGAAAACCCATCTCC</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">rs3901533<xref ref-type="table-fn" rid="TN2"><sup>#</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Forward</td>
<td align="left" colspan="2" rowspan="1" valign="top">CTGGGAAAGGCAAAGAGGGTT</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">614 bp</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Reverse</td>
<td align="left" colspan="2" rowspan="1" valign="top">TTAGCCATTGTCTTCTCCTCCAA</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="6" rowspan="1" valign="top"><bold>(B) Restriction digestion conditions and expected fragments size</bold>.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Polymorphic sites</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Enzyme</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>RFLP conditions</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Wild-type homozygotes (bp)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Variant homozygotes (bp)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Heterozygotes (bp)</bold>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">G&gt;A (rs11053593)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HindIII-HF</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4 h at 37°C</td>
<td align="left" colspan="1" rowspan="1" valign="top">354+197</td>
<td align="left" colspan="1" rowspan="1" valign="top">551</td>
<td align="left" colspan="1" rowspan="1" valign="top">354+197+551</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">G&gt;T (rs11053597)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HaeIII</italic>
</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">325+226</td>
<td align="left" colspan="1" rowspan="1" valign="top">551</td>
<td align="left" colspan="1" rowspan="1" valign="top">325+226+551</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">T&gt;G (rs3901533)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ApoI-HF</italic>
</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">371+119+124</td>
<td align="left" colspan="1" rowspan="1" valign="top">371+243</td>
<td align="left" colspan="1" rowspan="1" valign="top">371+243+119+124</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>“*”</label>
<p><italic>Denote SNPs reported at forward strand</italic>,</p>
</fn>
<fn id="TN2">
<label>“#”</label>
<p><italic>denote SNPs reported at Reverse strand in NCBI dbSNP database</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Choice of restriction enzymes for PCR-RFLP</title>
<p>The online tool NEBcutter v 2.0 (<ext-link ext-link-type="uri" xlink:href="http://www.neb.uk.com/tools/index.aspx?req=nebcutter">http://www.neb.uk.com/tools/index.aspx?req=nebcutter</ext-link>) was employed for the selection of restriction enzymes, which are able to distinguish between the wild and variant alleles related to SNPs rs11053593, rs11053597, and rs3901533 (Vincze et al., <xref ref-type="bibr" rid="B74">2003</xref>). The simulation of DNA cutting by the proposed enzymes on gel and the analysis of the foreseen restriction profiles were also performed. Restriction endonuclease analysis of 20 μl of amplified PCR product was performed, using 1 unit of restriction enzyme and 1X NEBuffer (cut smart). Restriction endonucleases (New England BioLabs, Beverly, USA) chosen for each SNP along with the conditions considered are given in Table <xref ref-type="table" rid="T1">1B</xref>. Restriction digestion was detected by 3% (w/v) agarose gel electrophoresis. Specific banding pattern of restricted PCR products obtained on gel was used to determine genotypes (Figure <xref ref-type="fig" rid="F2">2</xref>). Verification of representative genotypes was done by Sanger sequencing (Figure <xref ref-type="fig" rid="F2">2</xref>). These sequences were analyzed using the tool chromas 2.6.4 (<ext-link ext-link-type="uri" xlink:href="http://technelysium.com.au/wp/chromas/">http://technelysium.com.au/wp/chromas/</ext-link>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>The detected polymorphisms of <italic>CLEC7A</italic>. Sequencing analyses indicating the presence of <bold>(A)</bold> rs11053593, <bold>(B)</bold> rs11053597, and <bold>(C)</bold> rs3901533. Representative digestion showing polymorphism. M: 100 bp DNA ladder (GeNei, Banglore). N: negative control (PCR product with no restriction enzymes).</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0002"></graphic>
</fig>
</sec>
</sec>
<sec>
<title>Serum concentrations of dectin-1 and MBL</title>
<p>Commercially available enzyme linked immnosorbent assay (ELISA) kits was used to quantify dectin-1 levels in serum according to manufacturer's instructions. This kit is capable of recognizing all isoforms of dectin-1 (Ray Biotech, USA). Detection limits were 0.082–20 ng/ml. The serum samples were pre-diluted 2 fold before use. Serum MBL (sMBL) quantification was also performed by commercially available ELISA kits as reported previously (Kalia et al., <xref ref-type="bibr" rid="B37">2017</xref>).</p>
</sec>
<sec>
<title>Statistics</title>
<p>The sample size, required for the present study with a power of 99% was determined by CaTS power calculator (<ext-link ext-link-type="uri" xlink:href="http://csg.sph.umich.edu/abecasis/CaTS/">http://csg.sph.umich.edu/abecasis/CaTS/</ext-link>) by taking conventions of odds ratio of 1.5, 5% significance level (<italic>p</italic> = 0.05) and 30% national prevalence of vaginal discharge. Allelic and genotypic frequencies of <italic>CLEC7A</italic> SNPs were calculated manually. Odds ratios (ORs) statistics at 95% confidence intervals was used to compare allelic and genotypic distribution of cases and controls. This statistical analysis was performed using MedCalc software v 9.3.9.0 (<ext-link ext-link-type="uri" xlink:href="https://www.medcalc.org/">https://www.medcalc.org/</ext-link>). Inheritance models and hardy-Weinberg equilibrium were assessed by SNPStats (<ext-link ext-link-type="uri" xlink:href="https://www.snpstats.net/snpstats/start.htm">https://www.snpstats.net/snpstats/start.htm</ext-link>), a tool based on binary logistic regression analysis (Solé et al., <xref ref-type="bibr" rid="B67">2006</xref>). The choice of best inheritance model for each SNP was made by selecting model with lowest score of Akaike's Information Criterion and Bayesian Information Criterion given by SNPStats. Haploview v 4.2 was used to perform linkage disequilibrium analysis (Barrett et al., <xref ref-type="bibr" rid="B3">2004</xref>). PHASE software v 2.1.1 was used to construct and estimate haplotype frequencies (Stephens et al., <xref ref-type="bibr" rid="B68">2001</xref>). <italic>p</italic>-values ≤ 0.05 were considered significant. The allele and corresponding homozygous genotype with highest frequencies in the total subjects were taken as reference (OR = 1). One way analysis of variance (ANOVA) followed by <italic>post hoc</italic> Tukey's test was performed to compare serum levels (mean ± S.E.M) within group. Student's <italic>t</italic>-test was used to compare serum levels of cases with respective controls. The correlation between serum biomarkers was calculated by Pearson's correlation coefficient analysis. SPSS statistical package v 16.0 was used for these statistical analyses.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec>
<title><italic>In silico</italic> analysis and SNPs selection</title>
<p>The dbSNP is most considerable amongst all the available databases, though includes both validated as well as non-validated SNPs (Sherry et al., <xref ref-type="bibr" rid="B64">2001</xref>; Bhagwat, <xref ref-type="bibr" rid="B6">2010</xref>). Total 1,179 SNPs of <italic>CLEC7A</italic> are present in dbSNP in gene region view. Out of these, only 70 validated SNPs were found to have MAF ≥ 0.10. These SNPs comprised of only non-coding variants including two in 3′ near gene, thirteen in 3′ UTR region, forty nine in intronic region, one in 5′ UTR and five in 5′ near gene. Polymorphisms which are not validated or have MAF &lt; 0.10 were omitted from further analysis. As no non-synonymous SNPs (nsSNPs) were found to have MAF even ≥0.05, so SNPs in clinical source view were also checked for validation status and MAF. However, the results remain same. Even most commonly studied nsSNP of <italic>CLEC7A</italic> i.e., Y238X (rs16910526) has MAF of 0.040, which was not fulfilling the criteria and hence omitted. Thus, the present analysis involves only 70 non-coding SNPs of <italic>CLEC7A</italic>. A <italic>CLEC7A</italic> map marking these SNPs positions is demonstrated in Figure <xref ref-type="fig" rid="F3">3</xref>.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p><italic>CLEC7A</italic> map pointing the locations of 70 validated SNPs (MAF ≥ 0.10) based on dbSNP database. The whole <italic>CLEC7A</italic> gene structure contains 6 exons and spans <inline-graphic xlink:href="fcimb-08-00065-i0001.jpg"></inline-graphic> 16.0 kb. Estimate distances of various <italic>CLEC7A</italic> regions are designated in bp underneath. <sup>*</sup>indicate conserved SNPs (cSNPs).</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0003"></graphic>
</fig>
<p>In sequence alignment, all the species were found to show alignment with human <italic>CLEC7A</italic> except <italic>C. jacchus, C. lupus familiaris, F.catus, O. cuniculus R. norvegicus</italic>, and <italic>M. musculus</italic>. Only 26 conserved SNPs (cSNPs) were found, out of 70 non-coding SNPs of <italic>CLEC7A</italic> (Figure <xref ref-type="fig" rid="F3">3</xref>). These 26 cSNPs of <italic>CLEC7A</italic> falling in 3′ UTR and intron region were carried forward for further analysis in the present study. The results obtained after submitting 26 cSNPs to FuncPred are shown in Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>. Total nine SNPs including eight in 3′UTR region and one in intronic region were predicted to be affecting miRNA binding sites. In addition, one 3′UTR SNP rs12304716 was found to be affecting splicing also. RegulomeDB was further used to analyse these 26 cSNPs, which provided an annotation scores for 19 SNPs ranging from 4 to 6, representing weak or minimal binding evidence for the functional SNPs (Table <xref ref-type="supplementary-material" rid="SM2">S2</xref>). The remaining seven SNPs get no data annotation (not shown in Table <xref ref-type="supplementary-material" rid="SM2">S2</xref>). The 26 cSNPs submitted to PolymiRTS predicted four SNPs of 3′UTR region altering miRNA target sites, thus suggesting their likelihood in resulting truncated proteins (Table <xref ref-type="supplementary-material" rid="SM3">S3</xref>). Furthermore the findings of FuncPred were replicated in PolymiRTS for these 4 SNPs.</p>
<p>The screening of 26 cSNPs based on the putative function identified by four tools, is shown in Table <xref ref-type="table" rid="T2">2</xref>. Four 3′UTR SNPs i.e., rs10845047, rs11053594, rs11053595, and rs11053597 predicted by all the tools were selected for further analysis. However, the findings of all the tools were not exactly overlapping for other SNPs. Therefore, SNPs whose functionality has been pre-suggested and putatively identified by one or more tools were selected for further analysis. These SNPs included rs11053593, rs7959451, rs7309123, rs2078178, and rs3901533. As a result, total 9 non-coding SNPs from intronic and 3′ UTR region of <italic>CLEC7A</italic> were sorted out from a pool of SNPs and recognized as fundamental variants. Out of the nine functionally identified casual variants of the present study, PCR-RFLP could be standardized for three SNPs rs11053593, rs11053597, and rs3901533 and thus validated.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>List of Conserved SNPs (cSNPs) screened based on all the tools used.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Region</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>SNP ID</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>cSNPs</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>FuncPred</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>RegulomeDB score</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>PolymiRTS</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Selected</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs10845047</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="table-fn" rid="TN3">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs12304716</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11053592</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11053593<sup><inline-graphic xlink:href="fcimb-08-00065-i0003.jpg"></inline-graphic></sup></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="table-fn" rid="TN3">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11053594</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="table-fn" rid="TN3">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11053595</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="table-fn" rid="TN3">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11053597</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="table-fn" rid="TN3">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3′UTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs7959451<sup><inline-graphic xlink:href="fcimb-08-00065-i0003.jpg"></inline-graphic></sup></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="table-fn" rid="TN3">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs7309123<sup><inline-graphic xlink:href="fcimb-08-00065-i0003.jpg"></inline-graphic></sup></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="table-fn" rid="TN3">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11053602</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs58924693</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs5614055</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs59913193</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs7136680</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4764272</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11053608</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">5</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron5</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs7137840</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron4</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2078178<sup><inline-graphic xlink:href="fcimb-08-00065-i0003.jpg"></inline-graphic></sup></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="table-fn" rid="TN3">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron4</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs5796380</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron4</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs3901533<sup><inline-graphic xlink:href="fcimb-08-00065-i0003.jpg"></inline-graphic></sup></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<xref ref-type="table-fn" rid="TN3">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron4</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11053613</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron4</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs3901532</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron3</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs11053617</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron3</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs4763446</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron2</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs35532667</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">6</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Intron2</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs7309870</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">4</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>cSNPs, conserved SNPs; <inline-graphic xlink:href="fcimb-08-00065-i0002.jpg"></inline-graphic>, SNPs which affect function; –, SNPs which does not affect function</italic>;</p>
<fn id="TN3">
<label>*</label>
<p><italic>, prioritized for further studies</italic>;</p>
</fn>
<p><italic><inline-graphic xlink:href="fcimb-08-00065-i0003.jpg"></inline-graphic>, clinical significance has been reported (Sainz et al., <xref ref-type="bibr" rid="B61">2012</xref>; Bacanu et al., <xref ref-type="bibr" rid="B4">2014</xref>; Bennabi et al., <xref ref-type="bibr" rid="B5">2015</xref>; Fischer et al., <xref ref-type="bibr" rid="B19">2016</xref>; Overton et al., <xref ref-type="bibr" rid="B56">2016</xref>, <xref ref-type="bibr" rid="B57">2017</xref>)</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Influence of <italic>CLEC7A</italic> variants on the susceptibility to RVVI</title>
<p>Significantly low frequency of G allele of rs3901533 was found in RVVI cases than controls representing its role in protection against RVVI (<italic>p</italic> &lt; 0.0001; OR = 0.43; 95% CI = 0.33–0.57) (Table <xref ref-type="table" rid="T3">3</xref>). However, no difference was observed in allelic frequencies of rs11053593 and rs11053597 polymorphism of <italic>CLEC7A</italic> between RVVI cases and controls. For rs3901533 variant, the frequency of heterozygous (<italic>p</italic> = 0.004; OR = 0.53; 95% CI = 0.34–0.82) and homozygous GG genotype (<italic>p</italic> &lt; 0.0001; OR = 0.24; 95% CI = 0.14–0.40) was considerably low in RVVI cases comparative to controls and thus defending against RVVI. However, no difference was observed in genotypic frequencies of rs11053593 and rs11053597 polymorphisms of <italic>CLEC7A</italic> between RVVI cases and controls (Table <xref ref-type="table" rid="T4">4</xref>). All the hereditary models, excluding over-dominant, were significant for rs3901533 SNP. However, the log-additive model (<italic>p</italic> &lt; 0.0001; OR = 0.49; 95% CI = 0.38–0.63) was found to be the best (AIC = 606.7, BIC = 619.1) among these, representing that if the risk for TG is <italic>K</italic>, the risk for TT will be <italic>K</italic><sup>2</sup> indicating that T allele in homozygous carrier had a higher risk of RVVI than its heterozygous carrier. However, no inheritance models were found to be significant for rs11053593 and rs11053597 polymorphisms.</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Allelic frequencies distribution of <italic>CLEC7A</italic> polymorphisms in RVVI cases and controls.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Alleles</bold>
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>All subjects</bold>
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>RVVI cases</bold>
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Controls</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>RVVI cases vs. controls</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>(<italic>N</italic> = 461)</bold>
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>(<italic>N</italic> = 258)</bold>
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>(<italic>N</italic> = 203)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>OR (95% CI)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>p</italic>-value</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Freq (%)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Freq (%)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Freq (%)</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="6" rowspan="1" valign="top">rs11053593</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">G</td>
<td align="center" colspan="1" rowspan="1" valign="top">753 (82)</td>
<td align="center" colspan="1" rowspan="1" valign="top">423 (82)</td>
<td align="center" colspan="1" rowspan="1" valign="top">330 (81)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">A</td>
<td align="center" colspan="1" rowspan="1" valign="top">169 (18)</td>
<td align="center" colspan="1" rowspan="1" valign="top">93 (18)</td>
<td align="center" colspan="1" rowspan="1" valign="top">76 (19)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.95(0.68–1.33)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.78</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" valign="top">rs11053597</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">G</td>
<td align="center" colspan="1" rowspan="1" valign="top">751 (81)</td>
<td align="center" colspan="1" rowspan="1" valign="top">421 (82)</td>
<td align="center" colspan="1" rowspan="1" valign="top">330 (81)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">T</td>
<td align="center" colspan="1" rowspan="1" valign="top">171 (19)</td>
<td align="center" colspan="1" rowspan="1" valign="top">95 (18)</td>
<td align="center" colspan="1" rowspan="1" valign="top">76 (19)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.97 (0.70–1.36)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.90</td>
</tr>
<tr>
<td align="left" colspan="6" rowspan="1" valign="top">rs3901533</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">T</td>
<td align="center" colspan="1" rowspan="1" valign="top">526 (57)</td>
<td align="center" colspan="1" rowspan="1" valign="top">340 (66)</td>
<td align="center" colspan="1" rowspan="1" valign="top">186 (46)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">G</td>
<td align="center" colspan="1" rowspan="1" valign="top">396 (43)</td>
<td align="center" colspan="1" rowspan="1" valign="top">176 (34)</td>
<td align="center" colspan="1" rowspan="1" valign="top">220 (54)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.43 (0.33–0.57)</td>
<td align="center" colspan="1" rowspan="1" valign="top">&lt;0.0001<xref ref-type="table-fn" rid="TN11"><sup>*</sup></xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>OR, odds ratio; CI, confidence intervals</italic>;</p>
<fn id="TN11">
<label>*</label>
<p><italic>indicates highly significant values (p ≤ 0.0001)</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T4" position="float">
<label>Table 4</label>
<caption>
<p>Genotypic frequencies distribution of <italic>CLEC7A</italic> polymorphisms in RVVI cases and controls.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Genetic Models</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Genotype</bold>
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>RVVI Cases</bold>
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Controls</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>OR (95% CI)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>p</italic>-value</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>AIC</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>BIC</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>(<italic>N</italic> = 258)</bold>
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>(<italic>N</italic> = 203)</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Freq (%)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Freq (%)</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="8" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>rs11053593</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Codominant</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">168 (65.1)</td>
<td align="center" colspan="1" rowspan="1" valign="top">133 (65.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.71</td>
<td align="center" colspan="1" rowspan="1" valign="top">638.5</td>
<td align="center" colspan="1" rowspan="1" valign="top">655</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">G/A</td>
<td align="center" colspan="1" rowspan="1" valign="top">87 (33.7)</td>
<td align="center" colspan="1" rowspan="1" valign="top">64 (31.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.08 (0.73–1.60)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">A/A</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (1.2)</td>
<td align="center" colspan="1" rowspan="1" valign="top">6 (3.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.39 (0.10–1.61)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.19</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dominant</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">168 (65.1)</td>
<td align="center" colspan="1" rowspan="1" valign="top">133 (65.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.93</td>
<td align="center" colspan="1" rowspan="1" valign="top">638.5</td>
<td align="center" colspan="1" rowspan="1" valign="top">650.9</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">G/A-A/A</td>
<td align="center" colspan="1" rowspan="1" valign="top">90 (34.9)</td>
<td align="center" colspan="1" rowspan="1" valign="top">70 (34.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.02 (0.69–1.50)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Recessive</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G-G/A</td>
<td align="center" colspan="1" rowspan="1" valign="top">255 (98.8)</td>
<td align="center" colspan="1" rowspan="1" valign="top">197 (97.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.17</td>
<td align="center" colspan="1" rowspan="1" valign="top">636.6</td>
<td align="center" colspan="1" rowspan="1" valign="top">649</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">A/A</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (1.2)</td>
<td align="center" colspan="1" rowspan="1" valign="top">6 (3.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.39 (0.09–1.56)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Overdominant</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G-A/A</td>
<td align="center" colspan="1" rowspan="1" valign="top">171 (66.3)</td>
<td align="center" colspan="1" rowspan="1" valign="top">139 (68.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.62</td>
<td align="center" colspan="1" rowspan="1" valign="top">638.3</td>
<td align="center" colspan="1" rowspan="1" valign="top">650.7</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">G/A</td>
<td align="center" colspan="1" rowspan="1" valign="top">87 (33.7)</td>
<td align="center" colspan="1" rowspan="1" valign="top">64 (31.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.11 (0.75–1.64)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Log-additive</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.95 (0.67–1.35)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.78</td>
<td align="center" colspan="1" rowspan="1" valign="top">638.4</td>
<td align="center" colspan="1" rowspan="1" valign="top">650.8</td>
</tr>
<tr>
<td align="left" colspan="8" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>rs11053597</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Codominant</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">169 (65.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">130 (64.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.64</td>
<td align="center" colspan="1" rowspan="1" valign="top">639.9</td>
<td align="center" colspan="1" rowspan="1" valign="top">656.4</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">G/T</td>
<td align="center" colspan="1" rowspan="1" valign="top">83 (32.2)</td>
<td align="center" colspan="1" rowspan="1" valign="top">70 (34.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.91 (0.62–1.35)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">T/T</td>
<td align="center" colspan="1" rowspan="1" valign="top">6 (2.3)</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (1.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.54 (0.38–6.27)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.54</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dominant</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">169 (65.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">130 (64.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.74</td>
<td align="center" colspan="1" rowspan="1" valign="top">638.4</td>
<td align="center" colspan="1" rowspan="1" valign="top">650.8</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">G/T-T/T</td>
<td align="center" colspan="1" rowspan="1" valign="top">89 (34.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">73 (36.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.94 (0.64–1.38)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Recessive</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G-G/T</td>
<td align="center" colspan="1" rowspan="1" valign="top">252 (97.7)</td>
<td align="center" colspan="1" rowspan="1" valign="top">200 (98.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.51</td>
<td align="center" colspan="1" rowspan="1" valign="top">638.1</td>
<td align="center" colspan="1" rowspan="1" valign="top">650.5</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">T/T</td>
<td align="center" colspan="1" rowspan="1" valign="top">6 (2.3)</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (1.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.59 (0.39–6.43)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Overdominant</td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G-T/T</td>
<td align="center" colspan="1" rowspan="1" valign="top">175 (67.8)</td>
<td align="center" colspan="1" rowspan="1" valign="top">133 (65.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.6</td>
<td align="center" colspan="1" rowspan="1" valign="top">638.2</td>
<td align="center" colspan="1" rowspan="1" valign="top">650.6</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">G/T</td>
<td align="center" colspan="1" rowspan="1" valign="top">83 (32.2)</td>
<td align="center" colspan="1" rowspan="1" valign="top">70 (34.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.90 (0.61–1.33)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Log-additive</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.98 (0.69–1.39)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.9</td>
<td align="center" colspan="1" rowspan="1" valign="top">638.5</td>
<td align="center" colspan="1" rowspan="1" valign="top">650.9</td>
</tr>
<tr>
<td align="left" colspan="8" rowspan="1" style="background-color:#bbbdc0" valign="top">
<bold>rs3901533</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Codominant</td>
<td align="left" colspan="1" rowspan="1" valign="top">T/T</td>
<td align="center" colspan="1" rowspan="1" valign="top">120 (46.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">52 (25.6)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.004<xref ref-type="table-fn" rid="TN4"><sup>*</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">608.6</td>
<td align="center" colspan="1" rowspan="1" valign="top">625.1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">T/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">100 (38.8)</td>
<td align="center" colspan="1" rowspan="1" valign="top">82 (40.4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.53 (0.34–0.82)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">38 (14.7)</td>
<td align="center" colspan="1" rowspan="1" valign="top">69 (34.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.24 (0.14–0.40)</td>
<td align="center" colspan="1" rowspan="1" valign="top">&lt;0.0001<xref ref-type="table-fn" rid="TN5"><sup>**</sup></xref></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dominant</td>
<td align="left" colspan="1" rowspan="1" valign="top">T/T</td>
<td align="center" colspan="1" rowspan="1" valign="top">120 (46.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">52 (25.6)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">&lt;0.0001<xref ref-type="table-fn" rid="TN5"><sup>**</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">616.8</td>
<td align="center" colspan="1" rowspan="1" valign="top">629.2</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">T/G-G/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">138 (53.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">151 (74.4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.40 (0.27–0.59)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Recessive</td>
<td align="left" colspan="1" rowspan="1" valign="top">T/T-T/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">220 (85.3)</td>
<td align="center" colspan="1" rowspan="1" valign="top">134 (66.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">&lt;0.0001<xref ref-type="table-fn" rid="TN5"><sup>**</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">614.8</td>
<td align="center" colspan="1" rowspan="1" valign="top">627.2</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">G/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">38 (14.7)</td>
<td align="center" colspan="1" rowspan="1" valign="top">69 (34.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.33 (0.21–0.53)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Overdominant</td>
<td align="left" colspan="1" rowspan="1" valign="top">T/T-G/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">158 (61.2)</td>
<td align="center" colspan="1" rowspan="1" valign="top">121 (59.6)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.72</td>
<td align="center" colspan="1" rowspan="1" valign="top">638.4</td>
<td align="center" colspan="1" rowspan="1" valign="top">650.8</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">T/G</td>
<td align="center" colspan="1" rowspan="1" valign="top">100 (38.8)</td>
<td align="center" colspan="1" rowspan="1" valign="top">82 (40.4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.93 (0.64–1.36)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Log-additive</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.49 (0.38-0.63)</td>
<td align="center" colspan="1" rowspan="1" valign="top">&lt;0.0001<xref ref-type="table-fn" rid="TN5"><sup>**</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>606.7</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>619.1</bold>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Akaike's Information Criterion (AIC) and Bayesian Information Criterion (BIC), Bold values indicate low AIC/BIC value</italic>,</p>
<fn id="TN4">
<label>*</label>
<p><italic>indicates significant values (p ≤ 0.01)</italic>,</p>
</fn>
<fn id="TN5">
<label>**</label>
<p><italic>indicates significant values (p ≤ 0.001)</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Influence of <italic>CLEC7A</italic> variants on susceptibility to RVVI types</title>
<p>Comparisons of allelic and genotypic distribution were made between previously categorized RVVI cases (BV, VVC, and MI) and controls (Table <xref ref-type="table" rid="T5">5</xref>; Kalia et al., <xref ref-type="bibr" rid="B38">2015</xref>). For rs3901533 polymorphism, frequency of G allele and its homozygosity was appreciably low in BV (<italic>p</italic> = 0.0004; <italic>p</italic> = 0.0009 resp), VVC (<italic>p</italic> = 0.001; <italic>p</italic> = 0.002 resp) and MI cases (<italic>p</italic> = 0.0006; <italic>p</italic> = 0.002 resp) relative to controls and thus providing protection against RVVI types. However, heterozygosity for G allele was not found to be significantly different in either of the RVVI types comparative to controls. However, no difference was observed in allelic and genotypic frequencies of rs11053593 and rs11053597 polymorphism of <italic>CLEC7A</italic> between RVVI types and controls. Also, distribution of <italic>CLEC7A</italic> polymorphisms showed no difference between RVVI types (not shown in table). No homozygote for minor allele was observed in MI for rs11053593 polymorphism.</p>
<table-wrap id="T5" position="float">
<label>Table 5</label>
<caption>
<p>Distribution and comparison of genotypic and allelic frequencies of <italic>CLEC7A</italic> polymorphisms in RVVI categories and controls.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>No. (%) of controls</bold>
</th>
<th align="center" colspan="3" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>No. (%) of RVVI categories</bold>
</th>
<th align="center" colspan="6" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Genotypic and allelic comparison</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Controls (<italic>N</italic> = 203)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>BV (<italic>N</italic> = 97)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>VVC (<italic>N</italic> = 62)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>MI (<italic>N</italic> = 41)</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>BV vs. Controls</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>VVC vs. controls</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>MI vs. controls</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>OR (95% CI)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>p</italic>-value</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>OR (95% CI)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>p</italic>-value</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>OR (95% CI)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>p</italic>-value</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="11" rowspan="1" valign="top">
<bold>rs11053593</bold>
</td>
</tr>
<tr>
<td align="left" colspan="11" rowspan="1" valign="top">
<bold>Genotypes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GG</td>
<td align="center" colspan="1" rowspan="1" valign="top">133 (65.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">64 (65.90)</td>
<td align="center" colspan="1" rowspan="1" valign="top">44 (70.96)</td>
<td align="center" colspan="1" rowspan="1" valign="top">26 (63.41)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GA</td>
<td align="center" colspan="1" rowspan="1" valign="top">64 (31.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">32 (32.90)</td>
<td align="center" colspan="1" rowspan="1" valign="top">17 (27.41)</td>
<td align="center" colspan="1" rowspan="1" valign="top">15 (36.58)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.03 (0.61–1.74)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.88</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.80 (0.42–1.51)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.49</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.19 (0.59–2.41)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.61</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AA</td>
<td align="center" colspan="1" rowspan="1" valign="top">6 (3.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1 (1.03)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1 (1.61)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0 (0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.34 (0.04–2.93)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.33</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.50 (0.05–4.30)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.53</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">NA</td>
</tr>
<tr>
<td align="left" colspan="11" rowspan="1" valign="top">
<bold>Alleles</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">G</td>
<td align="center" colspan="1" rowspan="1" valign="top">330 (81.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">160 (82.47)</td>
<td align="center" colspan="1" rowspan="1" valign="top">105 (84.60)</td>
<td align="center" colspan="1" rowspan="1" valign="top">67 (81.70)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">A</td>
<td align="center" colspan="1" rowspan="1" valign="top">76 (19.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">34(17.52)</td>
<td align="center" colspan="1" rowspan="1" valign="top">19 (15.32)</td>
<td align="center" colspan="1" rowspan="1" valign="top">15 (18.29)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.92 (0.59–1.44)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.72</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.78 (0.45–1.35)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.38</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.97 (0.52–1.79)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.92</td>
</tr>
<tr>
<td align="left" colspan="11" rowspan="1" valign="top">
<bold>rs11053597</bold>
</td>
</tr>
<tr>
<td align="left" colspan="11" rowspan="1" valign="top">
<bold>Genotypes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GG</td>
<td align="center" colspan="1" rowspan="1" valign="top">130 (64.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">63 (64.94)</td>
<td align="center" colspan="1" rowspan="1" valign="top">43 (69.35)</td>
<td align="center" colspan="1" rowspan="1" valign="top">30(73.17)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GT</td>
<td align="center" colspan="1" rowspan="1" valign="top">70 (34.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">33 (34.02)</td>
<td align="center" colspan="1" rowspan="1" valign="top">18 (29.03)</td>
<td align="center" colspan="1" rowspan="1" valign="top">8 (19.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.97 (0.58–1.62)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.91</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.77 (0.41–1.44)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.42</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.49 (0.21–1.13)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.09</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TT</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (1.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1 (1.03)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1 (1.61)</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (7.31)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.68 (0.07–6.74)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.74</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00 (0.10–9.94)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.99</td>
<td align="center" colspan="1" rowspan="1" valign="top">4.33 (0.83–22.53)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.08</td>
</tr>
<tr>
<td align="left" colspan="11" rowspan="1" valign="top">
<bold>Alleles</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">G</td>
<td align="center" colspan="1" rowspan="1" valign="top">330 (81.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">159 (81.95)</td>
<td align="center" colspan="1" rowspan="1" valign="top">104 (83.87)</td>
<td align="center" colspan="1" rowspan="1" valign="top">68 (82.92)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">T</td>
<td align="center" colspan="1" rowspan="1" valign="top">76 (19.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">35 (18.04)</td>
<td align="center" colspan="1" rowspan="1" valign="top">20 (16.12)</td>
<td align="center" colspan="1" rowspan="1" valign="top">14 (17.07)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.95 (0.61–1.48)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.84</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.83 (0.48–1.43)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.51</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.89 (0.47–1.67)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.72</td>
</tr>
<tr>
<td align="left" colspan="11" rowspan="1" valign="top">
<bold>rs3901533</bold>
</td>
</tr>
<tr>
<td align="left" colspan="11" rowspan="1" valign="top">
<bold>Genotypes</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TT</td>
<td align="center" colspan="1" rowspan="1" valign="top">52 (25.6)</td>
<td align="center" colspan="1" rowspan="1" valign="top">37 (38.14)</td>
<td align="center" colspan="1" rowspan="1" valign="top">26 (41.93)</td>
<td align="center" colspan="1" rowspan="1" valign="top">18 (43.90)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TG</td>
<td align="center" colspan="1" rowspan="1" valign="top">82 (40.4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">45 (46.39)</td>
<td align="center" colspan="1" rowspan="1" valign="top">26 (41.93)</td>
<td align="center" colspan="1" rowspan="1" valign="top">19 (46.34)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.77 (0.44–1.34)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.36</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.63 (0.33–1.20)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.16</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.66 (0.32–1.39)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.28</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GG</td>
<td align="center" colspan="1" rowspan="1" valign="top">69 (34.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">15 (15.46)</td>
<td align="center" colspan="1" rowspan="1" valign="top">10 (16.12)</td>
<td align="center" colspan="1" rowspan="1" valign="top">4 (9.75)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.30 (0.15–0.61)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0009<xref ref-type="table-fn" rid="TN7"><sup>**</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.28 (0.12–0.65)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.002<xref ref-type="table-fn" rid="TN6"><sup>*</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.16 (0.05–0.52)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.002<xref ref-type="table-fn" rid="TN6"><sup>*</sup></xref></td>
</tr>
<tr>
<td align="left" colspan="11" rowspan="1" valign="top">
<bold>Alleles</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">T</td>
<td align="center" colspan="1" rowspan="1" valign="top">186 (46.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">119 (61.34)</td>
<td align="center" colspan="1" rowspan="1" valign="top">78 (62.90)</td>
<td align="center" colspan="1" rowspan="1" valign="top">55 (67.07)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">G</td>
<td align="center" colspan="1" rowspan="1" valign="top">220 (54.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">75 (38.65)</td>
<td align="center" colspan="1" rowspan="1" valign="top">46 (37.09)</td>
<td align="center" colspan="1" rowspan="1" valign="top">27 (32.92)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.53 (0.37–0.75)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0004<xref ref-type="table-fn" rid="TN7"><sup>**</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.49 (0.32–0.75)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.001<xref ref-type="table-fn" rid="TN7"><sup>**</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.41 (0.25–0.68)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0006<xref ref-type="table-fn" rid="TN7"><sup>**</sup></xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>OR, Odds Ratio; CI, Confidence Intervals; NA, not applicable</italic>;</p>
<fn id="TN6">
<label>*</label>
<p><italic>indicates high significant values (p ≤ 0.01)</italic>,</p>
</fn>
<fn id="TN7">
<label>**</label>
<p><italic>indicates highly significant values (p ≤ 0.001)</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Linkage disequilibrium and haplotypes</title>
<p>The Linkage disequilibrium (LD) analysis of the studied variants showed high LD between rs11053597 and rs11053593 (Figure <xref ref-type="fig" rid="F4">4</xref>). Both the SNPs i.e., rs11053597 and rs11053593 variants were not found to be in LD with rs3901533 variant. The <italic>CLEC7A</italic> haplotype (5′<bold>→</bold>3′) distribution was compared between groups (Table <xref ref-type="table" rid="T6">6</xref>). These haplotypes represents SNP rs3901533, rs11053597 and rs11053593 in first, second and third position respectively. Global significant difference (<italic>p</italic> = 0.01) in haplotype frequencies was observed between cases and controls. A total of eight <italic>CLEC7A</italic> haplotypes were observed in the present study, of which TGG, GGG, and TTA were observed with frequency ≥0.05 in both cases and controls and were considered common haplotypes. While other haplotypes GTA, TGA, TTG, GTG, and GGA were observed with frequency ≤0.05 either in cases or controls were considered as rare haplotypes. Independent analysis of individual haplotypes indicated significantly low frequency of GGG haplotype in total RVVI cases (<italic>p</italic> &lt; 0.0001), BV cases (<italic>p</italic> = 0.03), VVC cases (<italic>p</italic> = 0.03), and MI cases (<italic>p</italic> = 0.007) than controls. Similarly frequency of GTA haplotype was appreciably low in RVVI cases (<italic>p</italic> = 0.0003), BV cases (<italic>p</italic> = 0.002), VVC cases (<italic>p</italic> = 0.01), and MI cases (<italic>P</italic> = 0.04) than controls. Low frequency (<italic>p</italic> = 0.03) of GGA haplotype was observed in RVVI cases relative to controls.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p>Linkage Disequilibrium plot of <italic>CLEC7A</italic> variants in all the participants. Numbers signifies the D' value expressed as percentile.</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0004"></graphic>
</fig>
<table-wrap id="T6" position="float">
<label>Table 6</label>
<caption>
<p>Distribution and comparison of <italic>CLEC7A</italic> haplotypes in cases and controls.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Haplotypes (5′ → 3′)</bold>
</th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>No. (%) of controls</bold>
</th>
<th align="center" colspan="4" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>No. (%) of cases</bold>
</th>
<th align="center" colspan="8" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Haplotype comparison</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></th>
<th align="center" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Total RVVI cases</bold>
</th>
<th align="center" colspan="3" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Clinical categories of RVVI</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>RVVI vs. controls</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>BV vs. controls</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>VVC vs. controls</bold>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>MI vs. controls</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>(<italic>N</italic> = 406)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>(<italic>N</italic> = 516)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>BV (<italic>N</italic> = 194)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>VVC (<italic>N</italic> = 124)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>MI (<italic>N</italic> = 82)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>OR (95% CI)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>p</italic>-value</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>OR (95% CI)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>p</italic>-value</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>OR (95% CI)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>p</italic>-value</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>OR (95%CI)</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold><italic>p</italic>-value</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TGG</td>
<td align="center" colspan="1" rowspan="1" valign="top">143 (35.22)</td>
<td align="center" colspan="1" rowspan="1" valign="top">258 (50.00)</td>
<td align="center" colspan="1" rowspan="1" valign="top">86 (44.3)</td>
<td align="center" colspan="1" rowspan="1" valign="top">58 (46.7)</td>
<td align="center" colspan="1" rowspan="1" valign="top">40 (48.7)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GGG</td>
<td align="center" colspan="1" rowspan="1" valign="top">170 (41.87)</td>
<td align="center" colspan="1" rowspan="1" valign="top">145 (28.10)</td>
<td align="center" colspan="1" rowspan="1" valign="top">68 (35.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">42 (32.8)</td>
<td align="center" colspan="1" rowspan="1" valign="top">22 (26.8)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.47 (0.34–0.63)</td>
<td align="center" colspan="1" rowspan="1" valign="top">&lt;0.0001<xref ref-type="table-fn" rid="TN10"><sup>***</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.66 (0.45–0.98)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.03<xref ref-type="table-fn" rid="TN8"><sup>*</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.60 (0.38–0.96)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.03<xref ref-type="table-fn" rid="TN8"><sup>*</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.46 (0.26–0.81)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.007<xref ref-type="table-fn" rid="TN9"><sup>**</sup></xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TTA</td>
<td align="center" colspan="1" rowspan="1" valign="top">25 (6.15)</td>
<td align="center" colspan="1" rowspan="1" valign="top">55 (10.65)</td>
<td align="center" colspan="1" rowspan="1" valign="top">26 (13.4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">13 (10.4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">7 (8.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.21 (0.72–2.04)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.45</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.72 (0.93–3.18)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.07</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.28 (0.61–2.67)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.50</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.00 (0.40–2.48)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.99</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GTA</td>
<td align="center" colspan="1" rowspan="1" valign="top">33 (8.12)</td>
<td align="center" colspan="1" rowspan="1" valign="top">20 (3.87)</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (1.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2 (1.6)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2 (2.4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.33 (0.18–0.60)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.0003<xref ref-type="table-fn" rid="TN10"><sup>***</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.15 (0.04–0.50)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.002<xref ref-type="table-fn" rid="TN9"><sup>**</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.14 (0.03–0.64)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.01<xref ref-type="table-fn" rid="TN9"><sup>**</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">0.21 (0.04–0.94)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.04<xref ref-type="table-fn" rid="TN8"><sup>*</sup></xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TGA</td>
<td align="center" colspan="1" rowspan="1" valign="top">11 (2.70)</td>
<td align="center" colspan="1" rowspan="1" valign="top">15 (2.90)</td>
<td align="center" colspan="1" rowspan="1" valign="top">5 (2.5)</td>
<td align="center" colspan="1" rowspan="1" valign="top">4 (3.2)</td>
<td align="center" colspan="1" rowspan="1" valign="top">6 (7.3)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.75 (0.33–1.68)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.49</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.75 (0.25–2.24)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.61</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.89 (0.27–2.93)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.85</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.95 (0.67–5.59)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.21</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TTG</td>
<td align="center" colspan="1" rowspan="1" valign="top">7 (1.72)</td>
<td align="center" colspan="1" rowspan="1" valign="top">11 (2.13)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2 (1.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (2.4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2 (2.4)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.87 (0.33–2.29)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.78</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.47 (0.09–2.33)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.36</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.05 (0.26–4.22)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.93</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.02 (0.20–5.11)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.97</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GTG</td>
<td align="center" colspan="1" rowspan="1" valign="top">10 (2.46)</td>
<td align="center" colspan="1" rowspan="1" valign="top">9 (1.74)</td>
<td align="center" colspan="1" rowspan="1" valign="top">4 (2.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">2 (1.6)</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (3.6)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.49 (0.19–1.25)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.13</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.66 (0.20–2.18)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.50</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.49 (0.10 2.31)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.37</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.07 (0.28–4.08)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.91</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GGA</td>
<td align="center" colspan="1" rowspan="1" valign="top">7 (1.72)</td>
<td align="center" colspan="1" rowspan="1" valign="top">3 (0.58)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0 (0.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0 (0.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0 (0.0)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.23 (0.06–0.93)</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.03<xref ref-type="table-fn" rid="TN8"><sup>*</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">
<bold>–</bold>
</td>
<td align="center" colspan="1" rowspan="1" valign="top">NA</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">NA</td>
<td align="center" colspan="1" rowspan="1" valign="top">–</td>
<td align="center" colspan="1" rowspan="1" valign="top">NA</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Global p-value for case/control haplotype association was 0.01; NA, not applicable</italic>.</p>
<fn id="TN8">
<label>*</label>
<p><italic>p ≤ 0.05</italic>;</p>
</fn>
<fn id="TN9">
<label>**</label>
<p><italic>p ≤ 0.01</italic>;</p>
</fn>
<fn id="TN10">
<label>***</label>
<p><italic>p ≤ 0.001</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Serum levels of dectin-1 in RVVI cases and healthy controls</title>
<p>Significantly high sdectin-1 levels were observed in RVVI cases and its subtypes BV, VVC, and MI relative to controls (Figure <xref ref-type="fig" rid="F5">5</xref>). Also, high sDectin-1 levels were observed in RVVI and VVC cases than BV (<italic>p</italic> &lt; 0.05).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<p>Serum Dectin-1 levels in different categories of cases and healthy controls (HC). Dot plot showing distribution of sDectin-1 levels in cases and controls. Horizontal line represents the mean value. One Way ANOVA followed by <italic>Post hoc</italic> Tukey test. Categories with different letters are significantly different from each other at <italic>p</italic> &lt; 0.05.</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0005"></graphic>
</fig>
</sec>
<sec>
<title>Influence of <italic>CLEC7A</italic> genotypes on sDectin-1 levels</title>
<p>Segregation of sdectin-1 levels were made on the basis of <italic>CLEC7A</italic> genotypes in different cases and controls (Figures <xref ref-type="fig" rid="F6">6A–D</xref>). It was found that different genotypes of individual SNP showed no significant difference in sdectin-1 levels within controls. However, TT genotype of rs3901533 was contributing significantly high sDectin-1 levels than TG genotype in RVVI and VVC cases. For rs11053593, sdectin-1 levels for GG genotypes were significantly high than GA genotype in BV cases. No other difference in genotypic sdectin-1 levels were observed within cases. Also, significantly high sdectin-1 levels were found in genotypes of RVVI and its types relative to respective control genotypes in various <italic>CLEC7A</italic> polymorphisms.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption>
<p>Comparison of sDectin-1 levels in different <italic>CLEC7A</italic> genotypes. sdectin-1 levels (mean±standard error) segregation based on different genotypes of studied <italic>CLEC7A</italic> variants in controls with RVVI <bold>(A)</bold> and controls with RVVI types including BV <bold>(B)</bold> VVC <bold>(C)</bold> and MI <bold>(D)</bold>. Asterisks corresponds to Student's <italic>t</italic>-test comparing cases with respective controls (<sup>*</sup><italic>p</italic> &lt; 0.05; <sup>**</sup><italic>p</italic> &lt; 0.01; <sup>***</sup><italic>p</italic> &lt; 0.001). Letters corresponds to Tukey's multiple comparison test, where capital letters compare genotypic sdectin-1 levels of single polymorphism within controls and small letters compare genotypic sdectin-1 levels of single polymorphism within cases. Genotypes with different letters are significantly different from each other at <italic>p</italic> &lt; 0.05. Genotypes with no letters are excluded from statistical analysis due to their low number observed in present study.</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0006"></graphic>
</fig>
</sec>
<sec>
<title>Influence of <italic>CLEC7A</italic> haplotypes on sDectin-1 levels</title>
<p>Mean levels of sDectin-1 of individual haplotypes were also studied in different cases groups and controls (Figures <xref ref-type="fig" rid="F7">7A–D</xref>). sDectin-1 levels of haplotypes showed no difference within control. In RVVI cases, TTG haplotype was contributing significant high levels than all the other haplotypes of RVVI cases except TTA and GTG. In BV cases, significantly high dectin-1 levels were observed in GTG haplotype than all the other haplotypes. No significant difference in haplotypic sDectin-1 levels was observed within VVC and MI cases. Also, significant difference was observed in haplotypic sDectin-1 levels of RVVI cases and its types with respective controls haplotypes.</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption>
<p>Comparison of sDectin-1 levels in different <italic>CLEC7A</italic> haplotypes. sdectin-1 levels (mean±standard error) segregation based on different haplotypes of studied <italic>CLEC7A</italic> variants in controls with RVVI <bold>(A)</bold> and controls with RVVI types including BV <bold>(B)</bold> VVC <bold>(C)</bold> and MI <bold>(D)</bold>. Asterisks corresponds to Student's <italic>t</italic>-test comparing cases with respective controls (<sup>*</sup><italic>p</italic> &lt; 0.05; <sup>**</sup><italic>p</italic> &lt; 0.01; <sup>***</sup><italic>p</italic> &lt; 0.001). Letters corresponds to Tukey's multiple comparison test, where capital letters compare haplotypic sdectin-1 levels of single polymorphism within controls and small letters compare haplotypic sdectin-1 levels of single polymorphism within cases. Haplotypes with different letters are significantly different from each other at <italic>p</italic> &lt; 0.05. Haplotypes with no letters are excluded from statistical analysis due to their low number observed in present study.</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0007"></graphic>
</fig>
</sec>
<sec>
<title>Correlation between sDectin-1 and sMBL levels</title>
<p>Distribution of sMBL levels in RVVI cases and healthy controls have been reported previously, with significantly low sMBL levels in RVVI cases and its subtypes relative to controls (Figure <xref ref-type="fig" rid="F8">8</xref>; Kalia et al., <xref ref-type="bibr" rid="B37">2017</xref>). The correlation analysis between sDectin-1 and sMBL levels showed no significant correlation in all the studied groups including RVVI (<italic>p</italic> = 0.423; <italic>r</italic> = −0.012), BV (<italic>p</italic> = 0.330; <italic>r</italic> = 0.045), VVC (<italic>p</italic> = 0.062; <italic>r</italic> = −0.198), MI (<italic>p</italic> = 0.425; <italic>r</italic> = 0.031) and controls (<italic>p</italic> = 0.199; <italic>r</italic> = −0.060).</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption>
<p>The graphic of sMBL levels in all the studied groups: The donut representing sMBL levels in cases and controls. Figure reproduced from data of our previous report (Kalia et al., <xref ref-type="bibr" rid="B37">2017</xref>).</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0008"></graphic>
</fig>
</sec>
<sec>
<title>Influence of <italic>CLEC7A</italic> genotypes on sMBL levels</title>
<p>Segregation of sMBL levels were made on the basis of <italic>CLEC7A</italic> genotypes in different cases and controls (Figures <xref ref-type="fig" rid="F9">9A–D</xref>). For rs3901533 GG genotype was contributing significantly low sMBL levels than TT genotype in RVVI cases. However no other difference was found in genotypic sMBL levels of <italic>CLEC7A</italic> polymorphisms in RVVI categories and in controls. Also, RVVI cases and its types showed significantly low genotypic sMBL levels as compared to respective genotypes in controls for various <italic>CLEC7A</italic> polymorphisms.</p>
<fig id="F9" position="float">
<label>Figure 9</label>
<caption>
<p>Comparison of sMBL levels in different <italic>CLEC7A</italic> genotypes. sMBL levels (mean±standard error) segregation based on different genotypes of studied <italic>CLEC7A</italic> variants in controls with RVVI <bold>(A)</bold> and controls with RVVI types including BV <bold>(B)</bold> VVC <bold>(C)</bold> and MI <bold>(D)</bold>. Asterisks corresponds to Student's <italic>t</italic>-test comparing cases with respective controls (<sup>*</sup><italic>p</italic> &lt; 0.05; <sup>**</sup><italic>p</italic> &lt; 0.01; <sup>***</sup><italic>p</italic> &lt; 0.001). Letters corresponds to Tukey's multiple comparison test, where capital letters compare genotypic sMBL levels of single polymorphism within controls and small letters compare genotypic sMBL levels of single Polymorphism within cases. Genotypes with different letters are significantly different from each other at <italic>p</italic> &lt; 0.05. Genotypes with no letters are excluded from statistical analysis due to their low number observed in present study.</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0009"></graphic>
</fig>
</sec>
<sec>
<title>Influence of <italic>CLEC7A</italic> haplotypes on sMBL levels</title>
<p>Individual <italic>CLEC7A</italic> haplotypes were also studied for the distribution of mean sMBL levels in cases and control groups (Figures <xref ref-type="fig" rid="F10">10A–D</xref>). In controls, GTA and TGA haplotypes were contributing significant low levels than GTG haplotype, while, no other difference was observed. In RVVI and VVC cases, GGG haplotype was contributing significant low levels than TGG haplotype, while no other differences were observed. Also, various haplotypes of RVVI and its categories were contributing significantly low sMBL levels than their respective haplotype in controls.</p>
<fig id="F10" position="float">
<label>Figure 10</label>
<caption>
<p>Comparison of sMBL levels in different <italic>CLEC7A</italic> haplotypes. sMBL levels (mean±standard error) segregation based on different haplotypes of studied <italic>CLEC7A</italic> variants in controls with RVVI <bold>(A)</bold> and controls with RVVI types including BV <bold>(B)</bold> VVC <bold>(C)</bold>, and MI <bold>(D)</bold>. Asterisks corresponds to Student's <italic>t</italic>-test comparing cases with respective controls (<sup>*</sup><italic>p</italic> &lt; 0.05; <sup>**</sup><italic>p</italic> &lt; 0.01; <sup>***</sup><italic>p</italic> &lt; 0.001). Letters corresponds to Tukey's multiple comparison test, where capital letters compare haplotypic sMBL levels of single polymorphism within controls and small letters compare haplotypic sMBL levels of single polymorphism within cases. Haplotypes with different letters are significantly different from each other at <italic>p</italic> &lt; 0.05. Haplotypes with no letters are excluded from statistical analysis due to their low number observed in present study.</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0010"></graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Recurrent vulvovaginal infections are the commonly reported microbiological syndrome affecting millions of women globally. Since many women develop RVVI without any known predisposing factor, there may be genetic predisposition that could act as a risk factor for RVVI in women (Bleicher and Stockdale, <xref ref-type="bibr" rid="B9">2015</xref>; Sobel, <xref ref-type="bibr" rid="B66">2016</xref>). Recently, we found that genetic polymorphisms in innate immune gene, Mannose binding Lectin (<italic>MBL2</italic>) and its low serum levels contributed as risk factors toward RVVI (Kalia et al., <xref ref-type="bibr" rid="B37">2017</xref>). However, our previous findings also suggested the probable contribution of several other host genes that may collectively confer risk of RVVI, further implying RVVI as a multifactorial/polygenic phenotype. Dectin-1 is another such important molecule of innate immunity that is best known for its role in antifungal defense and in providing defense against several other pathogens (Ferwerda et al., <xref ref-type="bibr" rid="B18">2009</xref>; Drummond and Brown, <xref ref-type="bibr" rid="B16">2013</xref>; Lefèvre et al., <xref ref-type="bibr" rid="B42">2013</xref>; Heyl et al., <xref ref-type="bibr" rid="B31">2014</xref>). Therefore, exploring whether the <italic>CLEC7A</italic> polymorphisms affects susceptibility to RVVI or not, is the purpose of the present study.</p>
<p>There are total 1179 SNPs in dbSNP database of human <italic>CLEC7A</italic> that have been identified. However, majority of these SNPs are still not functionally recognized. Therefore effort was made to haul out the most likely functional variants of <italic>CLEC7A</italic> using <italic>in silico</italic> analysis from the SNPs that may not have any function or of very low frequency (Bhatti et al., <xref ref-type="bibr" rid="B8">2006</xref>; Johnson, <xref ref-type="bibr" rid="B35">2009</xref>; Li and Wei, <xref ref-type="bibr" rid="B46">2015</xref>). In order to identify, putative functional significance of given SNPs, various complementary bioinformatics tools are used in the present study. This is because, a complete depiction of SNP functions, cannot be obtained by using single bioinformatics tool. Therefore, the tools used in the current analysis include SNPinfo, Ensembl, regulomeDB, and poylmiRTS. In order to avoid frequent pitfalls that occurs while carrying out an <italic>in silico</italic> analysis some essential features were considered. First is, verifying the consistency of a given SNP by considering its validation status (Fredman et al., <xref ref-type="bibr" rid="B21">2002</xref>). Second is, removing false-positive prophecy that occurs due to <italic>in silico</italic> tools, this is done by considering conserved SNPs only (Cartegni et al., <xref ref-type="bibr" rid="B13">2003</xref>; Yeo and Burge, <xref ref-type="bibr" rid="B80">2004</xref>). The third very important feature is the use of MAF. MAF is inversely proportional to the sample size of the study needed to detect risk allele (Grover et al., <xref ref-type="bibr" rid="B27">2007</xref>). This sample size further has a direct relationship with power of study to detect statistical significance. Therefore, MAF cut-off of ≥0.10 was considered for the present analysis. The fourth important feature was the use of literary evidences for the SNPs for which results from different tools were not directly overlapping. Thus by considering these important characteristics in mind and based on the results of tools used, nine non-coding SNPs of <italic>CLEC7A</italic> were found to be functionally important for disease association studies.</p>
<p>A very scanty data is available regarding role of these selected SNPs of <italic>CLEC7A</italic>. Of these, rs7309123 and rs3901533 SNPs were found to be associated with increased susceptibility to invasive pulmonary aspergillosis (IPA) infection and rs7309123 with developing invasive fungal diseases in patient with Acute Myeloid Leukemia (AML) as well as severe asthma with fungal sensitization (SAFS) (Sainz et al., <xref ref-type="bibr" rid="B61">2012</xref>; Fischer et al., <xref ref-type="bibr" rid="B19">2016</xref>; Overton et al., <xref ref-type="bibr" rid="B57">2017</xref>). rs2078178 influences the autism spectrum disorders (ASD) risk (Bennabi et al., <xref ref-type="bibr" rid="B5">2015</xref>). These reports validate and complement the findings of the current study. However, the role of rs3901533 in AML and fungal keratitis, rs7959451 in SAFS, rs7309123 in allergic bronchopulmonary aspergillosis (ABPA) in asthma were evaluated but no association were found with the diseases studied perhaps due to genetic heterogeneity found in different ethnicities or due to disease specificity (Qu et al., <xref ref-type="bibr" rid="B59">2015</xref>; Fischer et al., <xref ref-type="bibr" rid="B19">2016</xref>; Overton et al., <xref ref-type="bibr" rid="B56">2016</xref>, <xref ref-type="bibr" rid="B57">2017</xref>). Moreover, no clinical significance of rs10845047, rs11053594, rs11053595, and rs11053597 is recognized till date. Therefore, more studies in clinical settings are needed to verify these nine functionally important SNPs reported in the present study. Therefore, effort was made in this study to investigate their role in RVVI.</p>
<p>As most of the SNPs that were predicted to be functional by <italic>in silico</italic> analysis are new and those which were reported are genotyped solely based on direct sequencing or other technique like pyro-sequencing, TaqMan assay and so forth that requires the purchase of expensive equipment or chemicals. Therefore, effort was made in this study to standardize a straight forward method for genotyping/validating these polymorphisms i.e., polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP) which is inexpensive, simple and convenient method for SNP genotyping (Ota et al., <xref ref-type="bibr" rid="B55">2007</xref>). Fortunately, we were able to design PCR-RFLP for three SNPs i.e., rs11053593, rs11053597, and rs3901533 that can be confidently used as a cheaper alternative genotyping method for these sites. While other target SNPs were not found to be suitable for commercial restriction enzymes, or inversely, the sequence of <italic>CLEC7A</italic> for particular SNP have numerous restriction sites for a given restriction enzyme thus limiting the use of this technique for these SNPs. Therefore, the aforesaid 3 <italic>CLEC7A</italic> variants are the focus of the present study. Furthermore, the role of these variants in RVVI and its types has not been investigated earlier, making the current analysis first approach toward it. Also, the frequency distribution of 3 <italic>CLEC7A</italic> variants is reported for the first time by the present study in Indian population. rs11053593_A, rs11053597_T, and rs3901533_G were found to be minor alleles with MAF 0.18, 0.19 and 0.43 respectively. This is in consonance with overall MAF and MAF of individual populations of 1000 genome project for these SNPs (Table <xref ref-type="supplementary-material" rid="SM4">S4</xref>). However, a skew in the frequency of rs3901533 SNP was observed in American and European population leading to an excess of rare variant which is in contrast to the present study.</p>
<p><italic>CLEC7A</italic> rs3901533 polymorphism was found to be modulating the susceptibility for RVVI and its types. Its minor allele and its homozygosity were significantly lowering the risk of developing RVVI and its types, whereas homozygous carriers of its major allele were at risk. No study has assessed the role of rs3901533 polymorphism in relation to RVVI and its types. However, these results are in agreement with previous study reporting the significant association of this SNP with increased risk of IPA infection (Sainz et al., <xref ref-type="bibr" rid="B61">2012</xref>). But in contrast to the studies that have found no association of <italic>CLEC7A</italic> rs3901533 with fungal keratitis and AML (Qu et al., <xref ref-type="bibr" rid="B59">2015</xref>; Fischer et al., <xref ref-type="bibr" rid="B19">2016</xref>). The above inconsistency in results might stem from genetic heterogeneity found in different ethnicities or due to disease specificity, thus must be evaluated in different population. Stratification based on <italic>CLEC7A</italic> haplotypes indicated that GGG (rs3901533_G) and GTA (rs3901533_G) haplotypes have provided significant protection against RVVI (OR; 0.47, 0.33 resp.), BV (OR; 0.66, 0.15 resp.), VVC (OR; 0.60, 0.14 resp.) and MI (OR; 0.46, 0.21 resp.). These findings suggested minor allele of rs3901533 as an important marker for providing defense against RVVI and its types.</p>
<p>Significantly high sdectin-1 levels were detected in RVVI cases and its various categories than controls, suggesting high sdectin-1 levels as a disease specifier for RVVI and its types. Among RVVI types, VVC showed significantly high sdectin-1 levels than BV and MI. This is in consonance with an earlier study that showed increased intracellular expression of dectin-1 in neutrophils after <italic>C. albicans</italic> stimulation (Li D. et al., <xref ref-type="bibr" rid="B44">2012</xref>). As dectin-1 pathway activates unconventional protein secretion, it may effectively induce secretion of its soluble form by unconventional means in serum (Öhman et al., <xref ref-type="bibr" rid="B54">2014</xref>). Higher organisms employed an influential regulatory system i.e., alternative splicing for producing distinct functional proteins form same precursor mRNA that significantly explains proteomic complexity (Mummidi et al., <xref ref-type="bibr" rid="B52">2001</xref>). These different functional proteins from a single gene either influence or cross-regulate the performance of the other isoforms. Some supporting examples includes, two isoforms of mouse dectin-1, that are functionally different in identifying zymosan and producing TNF-alpha and the same properties are also shared by corresponding human dectin-1 isoforms (Heinsbroek et al., <xref ref-type="bibr" rid="B30">2006</xref>). Another example, where one spliced isoform influences the function of another original full length isoform is CD40 (Tone et al., <xref ref-type="bibr" rid="B70">2001</xref>). Similarly, whether this soluble form of dectin-1 up-regulates or down-regulates the expression of other dectin-1 isoforms, particularly its transmembrane form, remains elusive (Figure <xref ref-type="fig" rid="F11">11</xref>).</p>
<fig id="F11" position="float">
<label>Figure 11</label>
<caption>
<p>A conceptual model of defense by dectin-1 and regulation by its circulatory form. See text for citations.</p>
</caption>
<graphic xlink:href="fcimb-08-00065-g0011"></graphic>
</fig>
<p>Association between <italic>CLEC7A</italic> polymorphisms and sdectin-1 levels were also investigated in the present study. Significantly high sdectin-1 levels were found in cases than controls for the corresponding genotypes and haplotypes, suggesting the active role played by dectin-1 in defense against pathogens causing RVVI. In RVVI and VVC, TG genotype contributed low sdectin-1 levels than wild TT genotype. In RVVI, TTG haplotype was contributing significantly high levels than all the other haplotypes of RVVI cases except TTA and GTG. In BV, GTG haplotype was contributing significant high levels than all the other haplotypes of BV cases. These observations suggest that irrespective of the observed haplotype region, there are other variants that may be involved in regulating sdectin-1 levels and hence cannot ignore.</p>
<p>Influence of the <italic>CLEC7A</italic> polymorphisms on sMBL levels, were also assessed. Considerably low sMBL levels were found in cases comparative to controls for the corresponding <italic>CLEC7A</italic> genotypes and haplotypes. Also in RVVI cases, GG genotype of rs3901533 contributed significantly low sMBL levels than TT genotype. In RVVI and VVC cases, GGG haplotype (rs3901533_G) was contributing significantly low sMBL levels than TGG (rs3901533_T). This shows that, rs3901533 SNP may be modulating sMBL levels via altering dectin-1 pathway that induces collaborative inflammatory responses and defense against RVVI. However, our other findings showed no significant correlation between sDectin-1 and sMBL levels in RVVI cases and controls. This further suggests that the association found between <italic>CLEC7A</italic> polymorphisms and sMBL levels may simply be due to co-activation of two PRRs against the same pathogenic stimuli i.e., RVVI. The only study that so far collaborate the two PRRs has showed increased intracellular levels of dectin-1 by MBL-arbitrated opsonophagocytosis of pathogens (Li D. et al., <xref ref-type="bibr" rid="B44">2012</xref>). Thus, further studies are needed to confirm the complex relationship between these two CLRs in RVVI.</p>
<p>In the present study, allelic and genotypic frequencies of dectin-1 polymorphisms are in Hardy Weinberg Equilibrium (HWE) except for rs3901533 (<italic>p</italic> &lt; 0.0001). This deviation from HWE is accredited to selection pressure or population admixture (Hosking et al., <xref ref-type="bibr" rid="B33">2004</xref>). The reason may possibly be participants belonging to same geological area, hospital based study or due to infectious diseases (Miller, <xref ref-type="bibr" rid="B48">1999</xref>; Ghosh, <xref ref-type="bibr" rid="B25">2008</xref>; Fumagalli et al., <xref ref-type="bibr" rid="B23">2009</xref>).</p>
<p>In conclusion, the present analysis demonstrated that 9 putative functional SNPs of <italic>CLEC7A</italic>. Many of these variants have not been explored much till date. The frequency distribution of three <italic>CLEC7A</italic> variants i.e., rs11053593, rs11053597, and rs3901533 are reported for the first time in a representative sample of Indian population. The method used for the genotyping of these SNPs constitutes a simple and reliable assay which is compatible to facilities found in most of the laboratories. Our study found novel associations of <italic>CLEC7A</italic> rs3901533 polymorphism and high sDectin-1 levels with RVVI and its types. The same polymorphism was also found to be associated with sMBL levels that require further studies to confirm the complex relationship, as the association may simply be due to same pathogenic stimuli. Thus, aforementioned novel associations can be used for examining women with RVVI for better diagnosis and treatments. These are the preliminary findings and future investigations, to assess the contribution of additional <italic>CLEC7A</italic> variants in RVVI, are required using reliable methods. Finally, functional studies are warranted to define the implication of <italic>CLEC7A</italic> SNPs and haplotypes on gene expression, mRNA stability as well as structural and physiological aspects of dectin-1. Also, genotype-phenotype correlations of the current analysis recommended the probable contribution of other host genes that may collectively confer risk of RVVI, further implying RVVI as a polygenic phenotype. These genes must be explored to explain the genetic factors that impact woman's tendency to develop RVVI.</p>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>NK reviewed the literature, was involved in design, performing experiments, analysis, interpretation, and drafted the manuscript. SS participated in sample collection and RVVI diagnosis. MK, JS, and SS contributed in the experimental design, data analysis, manuscript editing and supervision. All authors read and approved the final manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer HF and handling Editor declared their shared affiliation.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>The authors express their sincere gratitude to University Grants Commission, New Delhi, Govt. of India for providing Ph.D. fellowship to NK. Also this work was partially supported by the grant of DST-purse.</p>
</ack>
<sec id="s6" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2018.00065/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2018.00065/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Table1.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM2">
<media xlink:href="Table2.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM3">
<media xlink:href="Table3.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM4">
<media xlink:href="Table4.DOCX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariizumi</surname><given-names>K.</given-names></name><name><surname>Shen</surname><given-names>G. L.</given-names></name><name><surname>Shikano</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>S.</given-names></name><name><surname>Ritter</surname><given-names>R.</given-names></name><name><surname>Kumamoto</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>20157</fpage>–<lpage>20167</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M909512199</pub-id><pub-id pub-id-type="pmid">10779524</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atashili</surname><given-names>J.</given-names></name><name><surname>Poole</surname><given-names>C.</given-names></name><name><surname>Ndumbe</surname><given-names>P. M.</given-names></name><name><surname>Adimora</surname><given-names>A. A.</given-names></name><name><surname>Smith</surname><given-names>J. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies</article-title>. <source/>AIDS
<volume>22</volume>, <fpage>1493</fpage>–<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0b013e3283021a37</pub-id><pub-id pub-id-type="pmid">18614873</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>J. C.</given-names></name><name><surname>Fry</surname><given-names>B.</given-names></name><name><surname>Maller</surname><given-names>J. D.</given-names></name><name><surname>Daly</surname><given-names>M. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Haploview: analysis and visualization of LD and haplotype maps</article-title>. <source/>Bioinformatics
<volume>21</volume>, <fpage>263</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bth457</pub-id><pub-id pub-id-type="pmid">15297300</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacanu</surname><given-names>S. A.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Richardson</surname><given-names>K.</given-names></name><name><surname>Lai</surname><given-names>C. Q.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Functional SNPs are enriched for schizophrenia association signals</article-title>. <source/>Mol. Psychiatry
<volume>19</volume>, <fpage>276</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2013.33</pub-id><pub-id pub-id-type="pmid">23546170</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennabi</surname><given-names>M.</given-names></name><name><surname>Delorme</surname><given-names>R.</given-names></name><name><surname>Oliveira</surname><given-names>J.</given-names></name><name><surname>Fortier</surname><given-names>C.</given-names></name><name><surname>Lajnef</surname><given-names>M.</given-names></name><name><surname>Boukouaci</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Dectin-1 polymorphism: a genetic disease specifier in autism spectrum disorders?</article-title>
<source/>PLoS ONE
<volume>10</volume>:<fpage>e0137339</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0137339</pub-id><pub-id pub-id-type="pmid">26352598</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhagwat</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Searching NCBI's dbSNP database</article-title>. <source/>Curr. Protoc. Bioinform.
<volume>1</volume>, <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/0471250953.bi0119s32</pub-id><pub-id pub-id-type="pmid">21154707</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>A.</given-names></name><name><surname>Ziebarth</surname><given-names>J. D.</given-names></name><name><surname>Cui</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>PolymiRTS Database 3.0: linking polymorphisms in microRNAs and their target sites with human diseases and biological pathways</article-title>. <source/>Nucleic Acids Res.
<volume>42</volume>, <fpage>86</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1028</pub-id><pub-id pub-id-type="pmid">24163105</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatti</surname><given-names>P.</given-names></name><name><surname>Church</surname><given-names>D. M.</given-names></name><name><surname>Rutter</surname><given-names>J. L.</given-names></name><name><surname>Struewing</surname><given-names>J. P.</given-names></name><name><surname>Sigurdson</surname><given-names>A. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists</article-title>. <source/>Am. J. Epidemiol.
<volume>164</volume>, <fpage>794</fpage>–<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwj269</pub-id><pub-id pub-id-type="pmid">16923772</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bleicher</surname><given-names>J.</given-names></name><name><surname>Stockdale</surname><given-names>C. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Association between recurrent bacterial vaginosis and <italic>Helicobacter pylori</italic> infection: a case report</article-title>. <source/>Proc. Obstet. Gynecol.
<volume>5</volume>, <fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>A. P.</given-names></name><name><surname>Hong</surname><given-names>E. L.</given-names></name><name><surname>Hariharan</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>Y.</given-names></name><name><surname>Schaub</surname><given-names>M. A.</given-names></name><name><surname>Kasowski</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Annotation of functional variation in personal genomes using RegulomeDB</article-title>. <source/>Genome Res.
<volume>22</volume>, <fpage>1790</fpage>–<lpage>1797</lpage>. <pub-id pub-id-type="doi">10.1101/gr.137323.112</pub-id><pub-id pub-id-type="pmid">22955989</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>N.</given-names></name><name><surname>Dolman</surname><given-names>K. M.</given-names></name><name><surname>van Houdt</surname><given-names>M.</given-names></name><name><surname>Sta</surname><given-names>M.</given-names></name><name><surname>Roos</surname><given-names>D.</given-names></name><name><surname>Kuijpers</surname><given-names>T. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding</article-title>. <source/>J. Immunol.
<volume>180</volume>, <fpage>4124</fpage>–<lpage>4132</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.180.6.4124</pub-id><pub-id pub-id-type="pmid">18322223</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>G. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Dectin-1: a signalling non-TLR pattern-recognition receptor</article-title>. <source/>Nat. Rev. Immunol.
<volume>6</volume>, <fpage>33</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/nri1745</pub-id><pub-id pub-id-type="pmid">16341139</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cartegni</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>M. Q.</given-names></name><name><surname>Krainer</surname><given-names>A. R.</given-names></name></person-group> (<year>2003</year>). <article-title>ESEfinder: a web resource to identify exonic splicing enhancers</article-title>. <source/>Nucleic Acids Res.
<volume>31</volume>, <fpage>3568</fpage>–<lpage>3571</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg616</pub-id><pub-id pub-id-type="pmid">12824367</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>D. N.</given-names></name><name><surname>Barondes</surname><given-names>S. H.</given-names></name></person-group> (<year>1990</year>). <article-title>Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism</article-title>. <source/>J. Cell Biol.
<volume>110</volume>, <fpage>1681</fpage>–<lpage>1691</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.110.5.1681</pub-id><pub-id pub-id-type="pmid">2335567</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Pilar Jimenez-A</surname><given-names>M.</given-names></name><name><surname>Viriyakosol</surname><given-names>S.</given-names></name><name><surname>Walls</surname><given-names>L.</given-names></name><name><surname>Datta</surname><given-names>S. K.</given-names></name><name><surname>Kirkland</surname><given-names>T.</given-names></name><name><surname>Heinsbroek</surname><given-names>S. E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Susceptibility to Coccidioides species in C57BL/6 mice is associated with expression of a truncated splice variant of Dectin-1 (Clec7a)</article-title>. <source/>Genes Immun.
<volume>9</volume>, <fpage>338</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1038/gene.2008.23</pub-id><pub-id pub-id-type="pmid">18418396</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>R. A.</given-names></name><name><surname>Brown</surname><given-names>G. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Signalling C-type lectins in antimicrobial immunity</article-title>. <source/>PLoS Pathog.
<volume>9</volume>:<fpage>e1003417</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1003417</pub-id><pub-id pub-id-type="pmid">23935480</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisen</surname><given-names>D. P.</given-names></name><name><surname>Minchinton</surname><given-names>R. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Impact of mannose-binding lectin on susceptibility to infectious diseases</article-title>. <source/>Clin. Infect. Dis.
<volume>37</volume>, <fpage>1496</fpage>–<lpage>1505</lpage>. <pub-id pub-id-type="doi">10.1086/379324</pub-id><pub-id pub-id-type="pmid">14614673</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferwerda</surname><given-names>B.</given-names></name><name><surname>Ferwerda</surname><given-names>G.</given-names></name><name><surname>Plantinga</surname><given-names>T. S.</given-names></name><name><surname>Willment</surname><given-names>J. A.</given-names></name><name><surname>van Spriel</surname><given-names>A. B.</given-names></name><name><surname>Venselaar</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Human dectin-1 deficiency and mucocutaneous fungal infections</article-title>. <source/>N. Engl. J. Med.
<volume>361</volume>, <fpage>1760</fpage>–<lpage>1767</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0901053</pub-id><pub-id pub-id-type="pmid">19864674</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>M.</given-names></name><name><surname>Spies-Weisshart</surname><given-names>B.</given-names></name><name><surname>Schrenk</surname><given-names>K.</given-names></name><name><surname>Gruhn</surname><given-names>B.</given-names></name><name><surname>Wittig</surname><given-names>S.</given-names></name><name><surname>Glaser</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Polymorphisms of Dectin-1 and TLR2 predispose to invasive fungal disease in patients with acute myeloid leukemia</article-title>. <source/>PLoS ONE
<volume>11</volume>:<fpage>e0150632</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0150632</pub-id><pub-id pub-id-type="pmid">26963509</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsum</surname><given-names>U.</given-names></name><name><surname>Holst</surname><given-names>E.</given-names></name><name><surname>Larsson</surname><given-names>P. G.</given-names></name><name><surname>Vasquez</surname><given-names>A.</given-names></name><name><surname>Jakobsson</surname><given-names>T.</given-names></name><name><surname>Mattsby-Baltzaer</surname><given-names>I.</given-names></name></person-group> (<year>2005</year>). <article-title>Bacterial vaginosis–a microbiological and immunological enigma</article-title>. <source/>APMIS
<volume>113</volume>, <fpage>81</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0463.2005.apm1130201.x</pub-id><pub-id pub-id-type="pmid">15723682</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fredman</surname><given-names>D.</given-names></name><name><surname>Siegfried</surname><given-names>M.</given-names></name><name><surname>Yuan</surname><given-names>Y. P.</given-names></name><name><surname>Bork</surname><given-names>P.</given-names></name><name><surname>Lehvaslaiho</surname><given-names>H.</given-names></name><name><surname>Brookes</surname><given-names>A. J.</given-names></name></person-group> (<year>2002</year>). <article-title>HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources</article-title>. <source/>Nucleic Acids Res.
<volume>30</volume>, <fpage>387</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1093/nar/30.1.387</pub-id><pub-id pub-id-type="pmid">11752345</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>French</surname><given-names>L.</given-names></name><name><surname>Horton</surname><given-names>J.</given-names></name><name><surname>Matousek</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Abnormal vaginal discharge: what does and does not work in treating underlying causes</article-title>. <source/>J. Fam. Pract.
<volume>53</volume>, <fpage>890</fpage>–<lpage>895</lpage>. <pub-id pub-id-type="pmid">15527726</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fumagalli</surname><given-names>M.</given-names></name><name><surname>Pozzoli</surname><given-names>U.</given-names></name><name><surname>Cagliani</surname><given-names>R.</given-names></name><name><surname>Comi</surname><given-names>G. P.</given-names></name><name><surname>Riva</surname><given-names>S.</given-names></name><name><surname>Clerici</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions</article-title>. <source/>J. Exp. Med.
<volume>206</volume>, <fpage>1395</fpage>–<lpage>1408</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20082779</pub-id><pub-id pub-id-type="pmid">19468064</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerosa</surname><given-names>F.</given-names></name><name><surname>Baldani-Guerra</surname><given-names>B.</given-names></name><name><surname>Lyakh</surname><given-names>L. A.</given-names></name><name><surname>Batoni</surname><given-names>G.</given-names></name><name><surname>Esin</surname><given-names>S.</given-names></name><name><surname>Winkler-Pickett</surname><given-names>R. T.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells</article-title>. <source/>J. Exp. Med.
<volume>205</volume>, <fpage>1447</fpage>–<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20071450</pub-id><pub-id pub-id-type="pmid">18490488</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Evolution and selection of human leukocyte antigen alleles by <italic>Plasmodium falciparum</italic> infection</article-title>. <source/>Hum. Immunol.
<volume>69</volume>, <fpage>856</fpage>–<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1016/j.humimm.2008.08.294</pub-id><pub-id pub-id-type="pmid">18824049</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gringhuis</surname><given-names>S. I.</given-names></name><name><surname>Den Dunnen</surname><given-names>J.</given-names></name><name><surname>Litjens</surname><given-names>M.</given-names></name><name><surname>Van Der Vlist</surname><given-names>M.</given-names></name><name><surname>Wevers</surname><given-names>B.</given-names></name><name><surname>Bruijns</surname><given-names>S. C.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk</article-title>. <source/>Nat. Immunol.
<volume>10</volume>, <fpage>203</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1692</pub-id><pub-id pub-id-type="pmid">19122653</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grover</surname><given-names>D.</given-names></name><name><surname>Woodfield</surname><given-names>A. S.</given-names></name><name><surname>Verma</surname><given-names>R.</given-names></name><name><surname>Zandi</surname><given-names>P. P.</given-names></name><name><surname>Levinson</surname><given-names>D. F.</given-names></name><name><surname>Potash</surname><given-names>J. B.</given-names></name></person-group> (<year>2007</year>). <article-title>QuickSNP: an automated web server for selection of tagSNPs</article-title>. <source/>Nucleic Acids Res.
<volume>35</volume>, <fpage>115</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm329</pub-id><pub-id pub-id-type="pmid">17517769</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>P. E.</given-names></name><name><surname>Lamont</surname><given-names>R. F.</given-names></name><name><surname>Taylor-Robinson</surname><given-names>D.</given-names></name><name><surname>Morgan</surname><given-names>D. J.</given-names></name><name><surname>Ison</surname><given-names>C.</given-names></name><name><surname>Pearson</surname><given-names>J.</given-names></name></person-group> (<year>1994</year>). <article-title>Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage</article-title>. <source/>BMJ
<volume>308</volume>, <fpage>295</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.308.6924.295</pub-id><pub-id pub-id-type="pmid">8124116</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinsbroek</surname><given-names>S. E.</given-names></name><name><surname>Taylor</surname><given-names>P. R.</given-names></name><name><surname>Martinez</surname><given-names>F. O.</given-names></name><name><surname>Martinez-Pomares</surname><given-names>L.</given-names></name><name><surname>Brown</surname><given-names>G. D.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Stage-specific sampling by pattern recognition receptors during <italic>Candida albicans</italic> phagocytosis</article-title>. <source/>PLoS Pathog.
<volume>4</volume>:<fpage>e1000218</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000218</pub-id><pub-id pub-id-type="pmid">19043561</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinsbroek</surname><given-names>S. E.</given-names></name><name><surname>Taylor</surname><given-names>P. R.</given-names></name><name><surname>Rosas</surname><given-names>M.</given-names></name><name><surname>Willment</surname><given-names>J. A.</given-names></name><name><surname>Williams</surname><given-names>D. L.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Expression of functionally different dectin-1 isoforms by murine macrophages</article-title>. <source/>J. Immunol.
<volume>176</volume>, <fpage>5513</fpage>–<lpage>5518</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.176.9.5513</pub-id><pub-id pub-id-type="pmid">16622020</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyl</surname><given-names>K. A.</given-names></name><name><surname>Klassert</surname><given-names>T. E.</given-names></name><name><surname>Heinrich</surname><given-names>A.</given-names></name><name><surname>Müller</surname><given-names>M. M.</given-names></name><name><surname>Klaile</surname><given-names>E.</given-names></name><name><surname>Dienemann</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Dectin-1 is expressed in human lung and mediates the proinflammatory immune response to nontypeable <italic>Haemophilus influenzae</italic></article-title>. <source/>Am. Soc. Microbiol.
<volume>5</volume>, <fpage>e01492</fpage>–<lpage>e01414</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.01492-14</pub-id><pub-id pub-id-type="pmid">25161190</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>R. J.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Pierson</surname><given-names>J. D.</given-names></name><name><surname>Ravel</surname><given-names>J.</given-names></name><name><surname>Forney</surname><given-names>L. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Understanding vaginal microbiome complexity from an ecological perspective</article-title>. <source/>Transl. Res.
<volume>160</volume>, <fpage>267</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1016/j.trsl.2012.02.008</pub-id><pub-id pub-id-type="pmid">22683415</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosking</surname><given-names>L.</given-names></name><name><surname>Lumsden</surname><given-names>S.</given-names></name><name><surname>Lewis</surname><given-names>K.</given-names></name><name><surname>Yeo</surname><given-names>A.</given-names></name><name><surname>McCarthy</surname><given-names>L.</given-names></name><name><surname>Bansal</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Detection of genotyping errors by Hardy-Weinberg equilibrium testing</article-title>. <source/>Eur. J. Hum. Genet.
<volume>12</volume>, <fpage>395</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5201164</pub-id><pub-id pub-id-type="pmid">14872201</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>ICMR</collab></person-group> (<year>2006</year>). <source/>Indian Council of Medical Research: Ethical Guidelines for Biomedical Research on Human Participants. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.icmr.nic.in/">http://www.icmr.nic.in/</ext-link></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>A. D.</given-names></name></person-group> (<year>2009</year>). <article-title>Single-nucleotide polymorphism bioinformatics: a comprehensive review of resources</article-title>. <source/>Circ. Cardiovasc. Genet.
<volume>2</volume>, <fpage>530</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.109.872010</pub-id><pub-id pub-id-type="pmid">20031630</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>N.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Kaur</surname><given-names>M.</given-names></name><name><surname>Kamboj</surname><given-names>S. S.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>A comprehensive <italic>in silico</italic> analysis of non-synonymous and regulatory SNPs of human MBL2</article-title>. <source/>Springerplus
<volume>5</volume>, <fpage>1</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1186/s40064-016-2543-4</pub-id><pub-id pub-id-type="pmid">26759740</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Arora</surname><given-names>H.</given-names></name><name><surname>Kaur</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Genetic and phenotypic screening of Mannose-binding lectin in relation to risk of recurrent vulvovaginal infections in women of North India: a prospective cohort study</article-title>. <source/>Front. Microbiol.
<volume>8</volume>:<fpage>75</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.00075</pub-id><pub-id pub-id-type="pmid">28197138</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Kamboj</surname><given-names>S. S.</given-names></name><name><surname>Arora</surname><given-names>H.</given-names></name><name><surname>Kaur</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Prevalence of vulvovaginal infections and species specific distribution of vulvovaginal candidiasis in married women of north india</article-title>. <source/>Int. J. Curr. Microbiol. Appl. Sci.
<volume>4</volume>, <fpage>253</fpage>–<lpage>266</lpage>.</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasperkiewicz</surname><given-names>K.</given-names></name><name><surname>Swierzko</surname><given-names>A. S.</given-names></name><name><surname>Bartlomiejczyk</surname><given-names>M. A.</given-names></name><name><surname>Cedzynski</surname><given-names>M.</given-names></name><name><surname>Noszczynska</surname><given-names>M.</given-names></name><name><surname>Duda</surname><given-names>K. A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Interaction of human mannose-binding lectin (MBL) with Yersinia enterocolitica lipopolysaccharide</article-title>. <source/>Int. J. Med. Microbiol.
<volume>305</volume>, <fpage>544</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2015.07.001</pub-id><pub-id pub-id-type="pmid">26188838</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuchler</surname><given-names>K.</given-names></name><name><surname>Thorner</surname><given-names>J.</given-names></name></person-group> (<year>1990</year>). <article-title>Membrane translocation of proteins without hydrophobic signal peptides</article-title>. <source/>Curr. Opin. Cell Biol.
<volume>2</volume>, <fpage>617</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1016/0955-0674(90)90102-K</pub-id><pub-id pub-id-type="pmid">2252588</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>H.</given-names></name><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Pathogen recognition by the innate immune system</article-title>. <source/>Int. Rev. Immunol.
<volume>30</volume>, <fpage>16</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.3109/08830185.2010.529976</pub-id><pub-id pub-id-type="pmid">21235323</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefèvre</surname><given-names>L.</given-names></name><name><surname>Lugo-Villarino</surname><given-names>G.</given-names></name><name><surname>Meunier</surname><given-names>E.</given-names></name><name><surname>Valentin</surname><given-names>A.</given-names></name><name><surname>Olagnier</surname><given-names>D.</given-names></name><name><surname>Authier</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to <italic>Leishmania infantum</italic></article-title>. <source/>Immunity
<volume>38</volume>, <fpage>1038</fpage>–<lpage>1049</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2013.04.010</pub-id><pub-id pub-id-type="pmid">23684988</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeibundGut-Landmann</surname><given-names>S.</given-names></name><name><surname>Groß</surname><given-names>O.</given-names></name><name><surname>Robinson</surname><given-names>M. J.</given-names></name><name><surname>Osorio</surname><given-names>F.</given-names></name><name><surname>Slack</surname><given-names>E. C.</given-names></name><name><surname>Tsoni</surname><given-names>S. V.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17</article-title>. <source/>Nat. Immunol.
<volume>8</volume>, <fpage>630</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1038/ni1460</pub-id><pub-id pub-id-type="pmid">17450144</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Dong</surname><given-names>B.</given-names></name><name><surname>Tong</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>MBL-mediated opsonophagocytosis of <italic>Candida albicans</italic> by human neutrophils is coupled with intracellular Dectin-1-triggered ROS production</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e50589</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0050589</pub-id><pub-id pub-id-type="pmid">23239982</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>McCormick</surname><given-names>J.</given-names></name><name><surname>Bocking</surname><given-names>A.</given-names></name><name><surname>Reid</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>Importance of vaginal microbes in reproductive health</article-title>. <source/>Reprod. Sci.
<volume>19</volume>, <fpage>235</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1177/1933719111418379</pub-id><pub-id pub-id-type="pmid">22383775</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Wei</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Bioinformatics tools for discovery and functional analysis of single nucleotide polymorphisms</article-title>, in <source/>Advance in Structural Bioinformatics. Advances in Experimental Medicine and Biology, <volume>Vol. 827</volume>, eds <person-group person-group-type="editor"><name><surname>Wei</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Zhao</surname><given-names>T.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name></person-group> (<publisher-loc>Dordrecht</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>287</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1007/978-94-017-9245-5_17</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClelland</surname><given-names>R. S.</given-names></name><name><surname>Sangaré</surname><given-names>L.</given-names></name><name><surname>Hassan</surname><given-names>W. M.</given-names></name><name><surname>Lavreys</surname><given-names>L.</given-names></name><name><surname>Mandaliya</surname><given-names>K.</given-names></name><name><surname>Kiarie</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Infection with <italic>Trichomonas vaginalis</italic> increases the risk of HIV-1 acquisition</article-title>. <source/>J. Infect. Dis.
<volume>195</volume>, <fpage>698</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1086/511278</pub-id><pub-id pub-id-type="pmid">17262712</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>L. H.</given-names></name></person-group> (<year>1999</year>). <article-title>Evolution of the human genome under selective pressure from malaria: applications for control</article-title>. <source/>Parassitologia
<volume>41</volume>, <fpage>77</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="pmid">10697836</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>S. A.</given-names></name><name><surname>Dykes</surname><given-names>D. D.</given-names></name><name><surname>Polesky</surname><given-names>H. F.</given-names></name></person-group> (<year>1988</year>). <article-title>A simple salting out procedure for extracting DNA from human nucleated cells</article-title>. <source/>Nucleic Acids Res.
<volume>16</volume>:<fpage>1215</fpage>. <pub-id pub-id-type="doi">10.1093/nar/16.3.1215</pub-id><pub-id pub-id-type="pmid">3344216</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muesch</surname><given-names>A.</given-names></name><name><surname>Hartmann</surname><given-names>E.</given-names></name><name><surname>Rohde</surname><given-names>K.</given-names></name><name><surname>Rubartelli</surname><given-names>A.</given-names></name><name><surname>Sitia</surname><given-names>R.</given-names></name><name><surname>Rapoport</surname><given-names>T. A.</given-names></name></person-group> (<year>1990</year>). <article-title>A novel pathway for secretory proteins?</article-title>
<source/>Trends Biochem. Sci.
<volume>15</volume>, <fpage>86</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/0968-0004(90)90186-F</pub-id><pub-id pub-id-type="pmid">2139259</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulu</surname><given-names>W.</given-names></name><name><surname>Yimer</surname><given-names>M.</given-names></name><name><surname>Zenebe</surname><given-names>Y.</given-names></name><name><surname>Abera</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Common causes of vaginal infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot referral Hospital, Ethiopia: a cross sectional study</article-title>. <source/>BMC Womens. Health
<volume>15</volume>, <fpage>42</fpage>. <pub-id pub-id-type="doi">10.1186/s12905-015-0197-y</pub-id><pub-id pub-id-type="pmid">25968607</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mummidi</surname><given-names>S.</given-names></name><name><surname>Catano</surname><given-names>G.</given-names></name><name><surname>Lam</surname><given-names>L.</given-names></name><name><surname>Hoefle</surname><given-names>A.</given-names></name><name><surname>Telles</surname><given-names>V.</given-names></name><name><surname>Begum</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Extensive repertoire of membrane-bound and soluble dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2 isoforms inter-individual variation in expression of DC-SIGN transcripts</article-title>. <source/>J. Biol. Chem.
<volume>276</volume>, <fpage>33196</fpage>–<lpage>33212</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M009807200</pub-id><pub-id pub-id-type="pmid">11337487</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muthukrishnan</surname><given-names>L.</given-names></name><name><surname>Warder</surname><given-names>E.</given-names></name><name><surname>McNeil</surname><given-names>P. L.</given-names></name></person-group> (<year>1991</year>). <article-title>Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells</article-title>. <source/>J. Cell. Physiol.
<volume>148</volume>, <fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.1041480102</pub-id><pub-id pub-id-type="pmid">1860889</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Öhman</surname><given-names>T.</given-names></name><name><surname>Teirilä</surname><given-names>L.</given-names></name><name><surname>Lahesmaa-Korpinen</surname><given-names>A. M.</given-names></name><name><surname>Cypryk</surname><given-names>W.</given-names></name><name><surname>Veckman</surname><given-names>V.</given-names></name><name><surname>Saijo</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Dectin-1 pathway activates robust autophagy-dependent unconventional protein secretion in human macrophages</article-title>. <source/>J. Immunol.
<volume>192</volume>, <fpage>5952</fpage>–<lpage>5962</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1303213</pub-id><pub-id pub-id-type="pmid">24808366</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>M.</given-names></name><name><surname>Fukushima</surname><given-names>H.</given-names></name><name><surname>Kulski</surname><given-names>J. K.</given-names></name><name><surname>Inoko</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Single nucleotide polymorphism detection by polymerase chain reaction-restriction fragment length polymorphism</article-title>. <source/>Nat. Protoc.
<volume>2</volume>, <fpage>2857</fpage>–<lpage>2864</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2007.407</pub-id><pub-id pub-id-type="pmid">18007620</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Overton</surname><given-names>N. L.</given-names></name><name><surname>Denning</surname><given-names>D. W.</given-names></name><name><surname>Bowyer</surname><given-names>P.</given-names></name><name><surname>Simpson</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study</article-title>. <source/>Allergy Asthma Clin. Immunol.
<volume>12</volume>:<fpage>47</fpage>. <pub-id pub-id-type="doi">10.1186/s13223-016-0152-y</pub-id><pub-id pub-id-type="pmid">27708669</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Overton</surname><given-names>N. L.</given-names></name><name><surname>Simpson</surname><given-names>A.</given-names></name><name><surname>Bowyer</surname><given-names>P.</given-names></name><name><surname>Denning</surname><given-names>D. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Genetic susceptibility to severe asthma with fungal sensitization</article-title>. <source/>Int. J. Immunogenet.
<volume>44</volume>, <fpage>93</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1111/iji.12312</pub-id><pub-id pub-id-type="pmid">28371335</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>A. M.</given-names></name><name><surname>Nyirjesy</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Recurrent vulvovaginitis</article-title>. <source/>Best Pract. Res. Clin. Obstet. Gynaecol.
<volume>28</volume>, <fpage>967</fpage>–<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpobgyn.2014.07.006</pub-id><pub-id pub-id-type="pmid">25220102</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>X.</given-names></name><name><surname>Che</surname><given-names>C.</given-names></name><name><surname>Gao</surname><given-names>A.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Association of Dectin-1 and DC-SIGN gene single nucleotide polymorphisms with fungal keratitis in the northern Han Chinese population</article-title>. <source/>Mol. Vis.
<volume>21</volume>, <fpage>391</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="pmid">25883525</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosentul</surname><given-names>D. C.</given-names></name><name><surname>Delsing</surname><given-names>C. E.</given-names></name><name><surname>Jaeger</surname><given-names>M.</given-names></name><name><surname>Plantinga</surname><given-names>T. S.</given-names></name><name><surname>Oosting</surname><given-names>M.</given-names></name><name><surname>Costantini</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis</article-title>. <source/>Front. Microbiol.
<volume>5</volume>:<fpage>483</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2014.00483</pub-id><pub-id pub-id-type="pmid">25295030</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sainz</surname><given-names>J.</given-names></name><name><surname>Lupiá-ez</surname><given-names>C. B.</given-names></name><name><surname>Segura-Catena</surname><given-names>J.</given-names></name><name><surname>Vazquez</surname><given-names>L.</given-names></name><name><surname>Ríos</surname><given-names>R.</given-names></name><name><surname>Oyonarte</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e32273</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0032273</pub-id><pub-id pub-id-type="pmid">22384201</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoni</surname><given-names>G.</given-names></name><name><surname>Cardinali</surname><given-names>C.</given-names></name><name><surname>Morelli</surname><given-names>M. B.</given-names></name><name><surname>Santoni</surname><given-names>M.</given-names></name><name><surname>Nabissi</surname><given-names>M.</given-names></name><name><surname>Amantini</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Danger-and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons</article-title>. <source/>J. Neuroinflammation
<volume>12</volume>:<fpage>21</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0239-2</pub-id><pub-id pub-id-type="pmid">25644504</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherrard</surname><given-names>J.</given-names></name><name><surname>Donders</surname><given-names>G.</given-names></name><name><surname>White</surname><given-names>D.</given-names></name><name><surname>Jensen</surname><given-names>J. S.</given-names></name></person-group> (<year>2011</year>). <article-title>European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011</article-title>. <source/>Int. J. STD AIDS
<volume>22</volume>, <fpage>421</fpage>–<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1258/ijsa.2011.011012</pub-id><pub-id pub-id-type="pmid">21795415</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherry</surname><given-names>S. T.</given-names></name><name><surname>Ward</surname><given-names>M. H.</given-names></name><name><surname>Kholodov</surname><given-names>M.</given-names></name><name><surname>Baker</surname><given-names>J.</given-names></name><name><surname>Phan</surname><given-names>L.</given-names></name><name><surname>Smigielski</surname><given-names>E. M.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>dbSNP: the NCBI database of genetic variation</article-title>. <source/>Nucleic Acids Res.
<volume>29</volume>, <fpage>308</fpage>–<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id><pub-id pub-id-type="pmid">11125122</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobel</surname><given-names>J. D.</given-names></name></person-group> (<year>1988</year>). <article-title>Pathogenesis and epidemiology of vulvovaginal candidiasis</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>544</volume>, <fpage>547</fpage>–<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1988.tb40450.x</pub-id><pub-id pub-id-type="pmid">3063184</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobel</surname><given-names>J. D.</given-names></name></person-group> (<year>2016</year>). <article-title>Recurrent vulvovaginal candidiasis</article-title>. <source/>Am. J. Obstet. Gynecol.
<volume>214</volume>, <fpage>15</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2015.06.067</pub-id><pub-id pub-id-type="pmid">26164695</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solé</surname><given-names>X.</given-names></name><name><surname>Guinó</surname><given-names>E.</given-names></name><name><surname>Valls</surname><given-names>J.</given-names></name><name><surname>Iniesta</surname><given-names>R.</given-names></name><name><surname>Moreno</surname><given-names>V.</given-names></name></person-group> (<year>2006</year>). <article-title>SNPStats: a web tool for the analysis of association studies</article-title>. <source/>Bioinformatics
<volume>22</volume>, <fpage>1928</fpage>–<lpage>1929</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btl268</pub-id><pub-id pub-id-type="pmid">16720584</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stephens</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>N. J.</given-names></name><name><surname>Donnelly</surname><given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>A new statistical method for haplotype reconstruction from population data</article-title>. <source/>Am. J. Hum. Genet.
<volume>68</volume>, <fpage>978</fpage>–<lpage>989</lpage>. <pub-id pub-id-type="doi">10.1086/319501</pub-id><pub-id pub-id-type="pmid">11254454</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thulkar</surname><given-names>J.</given-names></name><name><surname>Kriplani</surname><given-names>A.</given-names></name><name><surname>Agarwal</surname><given-names>N.</given-names></name><name><surname>Vishnubhatla</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Aetiology &amp; risk factors of recurrent vaginitis &amp; its association with various contraceptive methods</article-title>. <source/>Indian J. Med. Res.
<volume>131</volume>, <fpage>83</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="pmid">20167978</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tone</surname><given-names>M.</given-names></name><name><surname>Tone</surname><given-names>Y.</given-names></name><name><surname>Fairchild</surname><given-names>P. J.</given-names></name><name><surname>Wykes</surname><given-names>M.</given-names></name><name><surname>Waldmann</surname><given-names>H.</given-names></name></person-group> (<year>2001</year>). <article-title>Regulation of CD40 function by its isoforms generated through alternative splicing</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>98</volume>, <fpage>1751</fpage>–<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.98.4.1751</pub-id><pub-id pub-id-type="pmid">11172023</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toth</surname><given-names>B.</given-names></name><name><surname>Würfel</surname><given-names>W.</given-names></name><name><surname>Bohlmann</surname><given-names>M. K.</given-names></name><name><surname>Gillessen-Kaesbach</surname><given-names>G.</given-names></name><name><surname>Nawroth</surname><given-names>F.</given-names></name><name><surname>Rogenhofer</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013)</article-title>. <source/>Geburtshilfe Frauenheilkunde
<volume>75</volume>, <fpage>1117</fpage>–<lpage>1129</lpage>. <pub-id pub-id-type="doi">10.1055/s-0035-1558299</pub-id><pub-id pub-id-type="pmid">26997666</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usluogullari</surname><given-names>B.</given-names></name><name><surname>Gumus</surname><given-names>I.</given-names></name><name><surname>Gunduz</surname><given-names>E.</given-names></name><name><surname>Kaygusuz</surname><given-names>I.</given-names></name><name><surname>Simavli</surname><given-names>S.</given-names></name><name><surname>Acar</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The role of human Dectin-1 Y238X gene polymorphism in recurrent vulvovaginal candidiasis infections</article-title>. <source/>Mol. Biol. Rep.
<volume>41</volume>, <fpage>6763</fpage>–<lpage>6768</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-014-3562-2</pub-id><pub-id pub-id-type="pmid">25008994</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Wijgert</surname><given-names>J. H.</given-names></name><name><surname>Borgdorff</surname><given-names>H.</given-names></name><name><surname>Verhelst</surname><given-names>R.</given-names></name><name><surname>Crucitti</surname><given-names>T.</given-names></name><name><surname>Francis</surname><given-names>S.</given-names></name><name><surname>Verstraelen</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The vaginal microbiota: what have we learned after a decade of molecular characterization?</article-title>
<source/>PLoS ONE
<volume>9</volume>:<fpage>e105998</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0105998</pub-id><pub-id pub-id-type="pmid">25148517</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincze</surname><given-names>T.</given-names></name><name><surname>Posfai</surname><given-names>J.</given-names></name><name><surname>Roberts</surname><given-names>R. J.</given-names></name></person-group> (<year>2003</year>). <article-title>NEBcutter: a program to cleave DNA with restriction enzymes</article-title>. <source/>Nucleic Acids Res.
<volume>31</volume>, <fpage>3688</fpage>–<lpage>3691</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkg526</pub-id><pub-id pub-id-type="pmid">12824395</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willment</surname><given-names>J. A.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>G. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Characterization of the human β-glucan receptor and its alternatively spliced isoforms</article-title>. <source/>J. Biol. Chem.
<volume>276</volume>, <fpage>43818</fpage>–<lpage>43823</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M107715200</pub-id><pub-id pub-id-type="pmid">11567029</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willment</surname><given-names>J. A.</given-names></name><name><surname>Marshall</surname><given-names>A. S.</given-names></name><name><surname>Reid</surname><given-names>D. M.</given-names></name><name><surname>Williams</surname><given-names>D. L.</given-names></name><name><surname>Wong</surname><given-names>S. Y.</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells</article-title>. <source/>Eur. J. Immunol.
<volume>35</volume>, <fpage>1539</fpage>–<lpage>1547</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200425725</pub-id><pub-id pub-id-type="pmid">15816015</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Medical Association</collab></person-group> (<year>2004</year>). <source/>Declaration of Helsinki. Note of Clarification on Paragraph 30 added by the WMA General Assembly. <publisher-loc>Tokyo</publisher-loc>.</mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Human Dectin-1 isoform E is a cytoplasmic protein and interacts with RanBPM</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>347</volume>, <fpage>1067</fpage>–<lpage>1073</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.07.021</pub-id><pub-id pub-id-type="pmid">16870151</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Taylor</surname><given-names>J. A.</given-names></name></person-group> (<year>2009</year>). <article-title>SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies</article-title>. <source/>Nucleic Acids Res.
<volume>37</volume>, <fpage>600</fpage>–<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkp290</pub-id><pub-id pub-id-type="pmid">19417063</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>G.</given-names></name><name><surname>Burge</surname><given-names>C. B.</given-names></name></person-group> (<year>2004</year>). <article-title>Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals</article-title>. <source/>J. Comput. Biol.
<volume>11</volume>, <fpage>377</fpage>–<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1089/1066527041410418</pub-id><pub-id pub-id-type="pmid">15285897</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahedi</surname><given-names>N.</given-names></name><name><surname>Kenari</surname><given-names>S. A.</given-names></name><name><surname>Mohseni</surname><given-names>S.</given-names></name><name><surname>Aslani</surname><given-names>N.</given-names></name><name><surname>Ansari</surname><given-names>S.</given-names></name><name><surname>Badali</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Is human Dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis?</article-title>
<source/>Curr. Med. Mycol.
<volume>2</volume>:<fpage>15</fpage>. <pub-id pub-id-type="doi">10.18869/acadpub.cmm.2.3.15</pub-id><pub-id pub-id-type="pmid">28681024</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>